info icon

Exclusions for E4_PCOS_BROAD

E4_PCOS_BROAD_EXCLUSIONS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C74, D35.2&, E22, E23, E24, E25, E27, Q96
  • Hospital discharge: ICD-9 2273|253|255|6116|2270|194
  • Hospital discharge: ICD-8 2262|253|255|258|2260
  • Cause of death: ICD-10 C74, D35.2&, E22, E23, E24, E25, E27, Q96
  • Cause of death: ICD-9 2273|253|255|6116|2270|194
  • Cause of death: ICD-8 2262|253|255|258|2260

2 out of 7 registries used, show all original rules.

7495

4. Check minimum number of events

None

7495

5. Include endpoints

None

7495

6. Filter based on genotype QC (FinnGen only)

7495

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF6v3

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 7495 4453 3042
Unadjusted period prevalence (%) 1.45 1.52 1.34
Median age at first event (years) 45.17 40.31 52.28

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
6697
Matched controls
66904
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G02CB01
ATC
bromocriptine; systemic
16.0
323.0
544
367
E23.05
ICD-10 Finland
Lack of TSH
867.9
323.0
331
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
2078.5
323.0
370
*
H03AA01
ATC
levothyroxine sodium; systemic
3.4
323.0
2259
8749
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
1449.9
323.0
534
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
603.2
323.0
940
18
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
9.4
323.0
713
835
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
+∞
323.0
1519
*
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
1861.1
323.0
373
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
10.8
323.0
1181
1296
105
Kela drug reimbursment
Adrenal cortical hypofunction
1704.2
323.0
315
*
N04BC06
ATC
cabergoline; oral (dopamine agonists)
162.1
323.0
496
33
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
2967.7
323.0
567
*
H02AB09
ATC
hydrocortisone; systemic
59.0
323.0
1883
440
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
229.4
323.0
896
45
E22.1
ICD-10 Finland
Hyperprolactinaemia
1386.2
323.0
1245
11
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
323.0
579
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
179.3
323.0
1122
75
H01AC01
ATC
somatropin; parenteral
73.2
309.9
355
51
102
Kela drug reimbursment
Diabetes insipidus
1401.2
276.6
268
*
E23.2
ICD-10 Finland
Diabetes insipidus
679.0
266.6
262
*
E23.03
ICD-10 Finland
Lack of ACTH
+∞
253.6
242
*
H02AA02
ATC
fludrocortisone; oral
36.2
246.4
321
93
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
2273.3
238.7
230
*
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
227.9
235.3
242
11
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
246.4
232.5
238
10
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
+∞
207.3
198
*
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
504.6
198.6
197
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
8.8
185.7
416
498
E27.0
ICD-10 Finland
Other adrenocortical overactivity
911.9
182.1
178
*
G02CB03
ATC
cabergoline; oral (prolactine inhibitors)
49.4
173.0
211
44
E23.06
ICD-10 Finland
Empty sella
+∞
160.0
153
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.5
156.8
829
2625
E22.2
ICD-10 Finland
Syndrome of inappropriate secretion of antidiuretic hormone
1583.5
155.7
151
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
5.7
153.7
472
882
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.9
142.6
998
3836
ZXC86
NOMESCO Finland
Use of endoscopic device
34.7
141.8
186
55
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
139.5
1337
6162
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
1326.7
133.7
130
*
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
328.0
128.9
130
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
128.6
1922
10847
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
127.7
2783
18157
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
8.9
126.6
281
329
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
105.1
122.4
134
13
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.6
118.6
590
1763
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
9.5
118.2
252
275
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
41.2
118.1
149
37
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
13.2
117.8
212
165
AA1AD
NOMESCO Finland
CT of head and brain
2.2
117.8
1528
8061
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
244.0
117.2
120
5
R53
ICD-10 Finland
Malaise and fatigue
2.2
115.4
1474
7713
E27.2
ICD-10 Finland
Addisonian crisis
+∞
111.7
107
*
301
Kela drug reimbursment
Growth hormone
38.0
107.6
138
37
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
107.5
1944
11659
G47.3
ICD-10 Finland
Sleep apnoea
2.1
106.7
1450
7756
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.9
104.7
365
782
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
992.2
100.3
98
*
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
+∞
98.1
94
*
N05AH04
ATC
quetiapine; oral
2.1
96.9
1254
6535
XCK00
NOMESCO Finland
Perimetry
3.2
96.2
549
1811
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
96.0
92
*
N91.1
ICD-10 Finland
Secondary amenorrhoea
6.4
94.9
261
421
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
94.3
1491
8424
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
93.1
1296
6953
E24.8
ICD-10 Finland
Other Cushing syndrome
+∞
91.8
88
*
C03CA01
ATC
furosemide; systemic
2.0
91.6
1496
8543
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
19.0
91.5
142
76
E22.80
ICD-10 Finland
Central precocious puberty
458.5
91.4
91
*
R51.80
ICD-10 Finland
Headache
2.1
90.0
1148
5922
E29.1
ICD-10 Finland
Testicular hypofunction
9.8
89.0
185
193
E23.6
ICD-10 Finland
Other disorders of pituitary gland
879.1
88.9
87
*
N06AX16
ATC
venlafaxine; oral
2.2
88.7
1046
5209
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
+∞
88.7
85
*
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
+∞
88.7
85
*
E27.9
ICD-10 Finland
Disorder of adrenal gland, unspecified
868.9
87.8
86
*
R06.0
ICD-10 Finland
Dyspnoea
1.9
87.8
1534
8959
N06AX21
ATC
duloxetine; oral
2.4
87.0
808
3580
H53.4
ICD-10 Finland
Visual field defects
5.7
85.2
255
458
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
+∞
84.5
81
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
84.0
1209
6540
N05BA04
ATC
oxazepam; oral
1.9
83.7
1620
9789
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
64.8
82.7
96
15
121
Kela drug reimbursment
Severe hypofunction of sexual glands
5.7
82.4
247
445
N06AX11
ATC
mirtazapine; oral
1.8
81.3
2020
13224
A02BC02
ATC
pantoprazole; systemic
1.6
79.3
3884
30683
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
79.2
679
2876
Y28
ICPC
Limited function/disability (Y)
20.7
77.0
116
57
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
76.9
1804
11560
N03AX16
ATC
pregabalin; oral
1.9
76.5
1462
8751
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
74.3
730
3316
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
74.1
969
5015
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
74.0
852
4171
H02AB06
ATC
prednisolone; systemic
1.6
73.1
2857
21089
N03AX12
ATC
gabapentin; oral
2.0
73.0
1003
5297
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
+∞
72.0
69
*
N06AB04
ATC
citalopram; systemic
1.8
71.9
1387
8303
G02CB04
ATC
quinagolide; oral
355.7
70.7
71
*
E34.35
ICD-10 Finland
Abnormal growth retardation
11.9
69.9
131
112
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
68.5
1331
7974
N02AX02
ATC
tramadol; systemic, rectal
1.6
68.1
2459
17678
UJF32
NOMESCO Finland
Coloscopy
1.8
67.9
1500
9365
BCA30
NOMESCO Finland
Unilateral adrenalectomy
53.9
67.0
80
15
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
65.9
921
4878
E25.9
ICD-10 Finland
Adrenogenital disorder, unspecified
643.8
65.0
64
*
N05CF01
ATC
zopiclone; oral
1.7
64.6
1858
12513
E23.08
ICD-10 Finland
Hypopituitarism
+∞
63.6
61
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
63.5
1198
7079
C07AB07
ATC
bisoprolol; oral
1.6
62.9
2448
17829
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
62.6
1386
8629
R11
ICD-10 Finland
Nausea and vomiting
2.4
62.2
597
2670
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
61.6
2277
16347
2542
FHL
Transasal hypophysectomy
+∞
61.5
59
*
D35.30
ICD-10 Finland
Craniopharyngoma
211.7
61.2
63
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
60.7
588
2640
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
60.4
753
3798
N02AA05
ATC
oxycodone; systemic
2.0
60.0
812
4236
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
16.3
60.0
98
61
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.1
59.9
757
3838
Z3231
NOMESCO Finland
Registered nurse
1.6
59.6
1781
12068
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.3
59.4
622
2899
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
+∞
59.4
57
*
A02BC05
ATC
esomeprazole; systemic
1.6
59.2
2359
17210
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
59.0
2481
18333
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
58.9
1002
5698
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
58.9
900
4922
J01MA12
ATC
levofloxacin; systemic
1.8
58.3
1069
6241
A02BC01
ATC
omeprazole; systemic
1.7
58.3
1598
10566
C03DA01
ATC
spironolactone; oral
2.3
58.1
610
2846
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
57.8
962
5425
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
57.7
752
3860
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.3
57.5
561
2525
E66.01
ICD-10 Finland
Obesity due to excess calories
2.3
57.5
581
2659
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
57.4
605
2825
25898
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Alii definiti
+∞
57.3
55
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
56.8
408
1554
R50.9
ICD-10 Finland
Fever, unspecified
1.9
56.8
968
5502
N02BE01
ATC
paracetamol; systemic, rectal
1.6
56.8
5272
46583
G03DB01
ATC
dydrogesterone; oral
2.0
56.7
862
4697
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
562.2
56.7
56
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
56.4
603
2832
N03AX09
ATC
lamotrigine; oral
2.7
56.1
404
1542
T99
ICPC
Endocr/metab/nutrit disease other
5.6
56.1
169
307
N06AA09
ATC
amitriptyline; systemic
2.2
55.7
626
3010
N05BA01
ATC
diazepam; systemic, rectal
2.0
55.4
835
4535
N05CD07
ATC
temazepam; oral
2.1
55.2
687
3452
SPAT1262
SPAT
Handing over of treatment supplies
1.8
55.0
1055
6238
N03AE01
ATC
clonazepam; systemic
2.6
55.0
419
1652
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
54.6
2180
15829
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.4
54.5
517
2290
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
54.4
1232
7678
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
54.1
1213
7534
E23.0
ICD-10 Finland
Hypopituitarism
531.7
53.6
53
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
53.4
2869
22259
E66.8
ICD-10 Finland
Other obesity
2.7
53.3
398
1550
J01FF01
ATC
clindamycin; systemic
1.6
53.1
1616
10943
N03AG01
ATC
valproic acid; systemic, rectal
2.4
52.3
475
2058
A06AD11
ATC
lactulose; oral
2.0
52.3
782
4225
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
+∞
52.1
50
*
E27.8
ICD-10 Finland
Other specified disorders of adrenal gland
+∞
52.1
50
*
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
52.0
647
3247
N05AH03
ATC
olanzapine; systemic
2.4
51.9
456
1942
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
51.2
471
2052
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
51.1
1171
7307
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
50.4
2568
19615
J01MA02
ATC
ciprofloxacin; systemic
1.5
50.0
2172
15999
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.0
50.0
207
525
R42
ICD-10 Finland
Dizziness and giddiness
1.7
49.5
1200
7607
R03AC02
ATC
salbutamol; inhalant
1.5
49.2
3253
26200
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
49.1
831
4691
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
49.1
1094
6762
E23.7
ICD-10 Finland
Disorder of pituitary gland, unspecified
251.8
49.1
50
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
48.9
1467
9862
J01DB01
ATC
cefalexin; oral
1.5
48.6
5170
45949
R03BB04
ATC
tiotropium bromide; inhalant
2.2
48.6
537
2556
TAB00
NOMESCO Finland
Lumbar puncture
2.7
48.3
358
1388
N06AB10
ATC
escitalopram; oral
1.7
48.0
1301
8506
25899
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Other and unspecified diseases of endocrine system
+∞
47.9
46
*
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
128.3
47.8
51
*
N05AX08
ATC
risperidone; systemic
2.2
47.8
508
2376
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
47.8
827
4704
SPAT1254
SPAT
Administration of medicine
1.8
47.7
925
5465
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
47.5
746
4097
L28
ICPC
Limited function/disability (L)
1.9
47.4
831
4747
ZXC95
NOMESCO Finland
Use of surgical navigator
6.1
47.0
132
220
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.4
47.0
235
699
M05BA04
ATC
alendronic acid; oral
2.4
46.8
437
1918
25510
ICD-8 Finland
Diseases of adrenal glands, Adrenal cortical hypofunction
+∞
45.9
44
*
2531A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]
+∞
45.9
44
*
104
Kela drug reimbursment
Thyroid insufficiency
2.3
45.8
457
2074
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
45.3
1373
9226
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
45.1
608
3147
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
44.9
555
2773
2533
FHL
Unilateral removal of additional egg
+∞
44.8
43
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
44.6
2663
20853
R03DC03
ATC
montelukast; oral
1.7
44.5
1015
6299
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
44.3
1603
11252
SPAT1263
SPAT
Sampling
1.5
44.1
2578
20084
N05AA02
ATC
levomepromazine; systemic
2.8
43.9
302
1118
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
43.8
1287
8569
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
43.7
598
3111
ZXD05
NOMESCO Finland
Urgent procedure
1.5
43.6
1872
13655
G44.2
ICD-10 Finland
Tension-type headache
1.8
43.1
832
4897
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
43.1
473
2243
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.7
42.4
196
547
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
42.4
492
2391
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
42.3
2029
15145
C07AA05
ATC
propranolol; systemic
1.6
42.2
1197
7886
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
42.1
442
2050
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
42.0
585
3066
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
41.8
452
2128
2551A
ICD-9 Finland
Disorders of adrenal glands, Hyperaldosteronism
+∞
41.7
40
*
ZX120
NOMESCO Finland
Intravenous
2.0
41.5
591
3120
R60.0
ICD-10 Finland
Localized oedema
2.0
41.3
608
3254
C08CA01
ATC
amlodipine; oral
1.5
41.1
1705
12309
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
41.0
402
1807
E25.01
ICD-10 Finland
Congenital adrenal hyperplasia
+∞
40.6
39
*
E25.00
ICD-10 Finland
Congenital salt-losing adrenal hyperplasia
+∞
40.6
39
*
A10BA02
ATC
metformin; oral
1.6
40.6
1353
9275
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
40.6
1262
8502
R03AK08
ATC
formoterol and beclometasone; inhalant
2.9
40.5
260
920
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
40.5
1346
9222
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.4
40.3
372
1622
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
40.0
2131
16207
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
39.9
1154
7629
SPAT1301
SPAT
No procedures
1.5
39.7
1832
13516
A02BC03
ATC
lansoprazole; oral
1.5
39.7
1565
11155
E24.2
ICD-10 Finland
Drug-induced Cushing syndrome
+∞
39.6
38
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
39.2
238
814
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.6
39.2
183
516
E0000UV
ATC
NA
1.4
39.1
2353
18312
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
39.0
938
5893
WX110
NOMESCO Finland
Local anesthesy
1.4
38.9
4327
37669
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
86.5
38.8
43
5
M79.6
ICD-10 Finland
Pain in limb
1.5
38.7
1998
15075
N05BA06
ATC
lorazepam; systemic, sublingual
2.5
38.7
325
1352
A02BA02
ATC
ranitidine; systemic
1.6
38.6
1034
6692
22620
ICD-8 Finland
Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)
+∞
38.6
37
*
N06AB03
ATC
fluoxetine; oral
1.8
38.5
770
4573
E66.00
ICD-10 Finland
Metabolic syndrome
2.5
38.3
327
1370
A46
ICD-10 Finland
Erysipelas
1.8
38.0
716
4175
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
6.6
38.0
100
154
R03BA05
ATC
fluticasone; inhalant
1.6
37.8
1129
7517
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
37.5
608
3367
CS494
NOMESCO Finland
Other visual field testing
3.8
37.4
166
449
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.9
37.0
236
834
A07AA02
ATC
nystatin; oral
2.3
36.7
363
1638
N05AX12
ATC
aripiprazole; systemic
2.5
36.6
298
1216
M54.5
ICD-10 Finland
Low back pain
1.5
36.6
1888
14209
S18
ICPC
Laceration/cut
1.4
36.5
2292
17913
2535A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Diabetes insipidus
+∞
36.5
35
*
SPAT1153
SPAT
Removal of sutures
1.5
36.4
1705
12573
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
36.2
249
922
H01CB02
ATC
octreotide; parenteral
16.7
36.2
58
35
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
36.2
1012
6616
H02AB04
ATC
methylprednisolone; systemic
1.7
35.9
826
5115
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.4
35.8
329
1433
J01MA14
ATC
moxifloxacin; systemic
2.0
35.5
506
2669
N06AB06
ATC
sertraline; oral
1.8
35.1
694
4098
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
35.0
763
4648
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.0
35.0
486
2537
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
34.8
381
1801
J02AC01
ATC
fluconazole; systemic
1.4
34.6
2308
18192
H47.2
ICD-10 Finland
Optic atrophy
9.7
34.6
71
74
25320
ICD-8 Finland
Diseases of pituitary gland, Chromophobe adenoma, pituitary
+∞
34.4
33
*
E23.3
ICD-10 Finland
Hypothalamic dysfunction, not elsewhere classified
+∞
34.4
33
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
5.3
34.3
107
204
A55
ICPC
General and Unspecified, Local injection/infiltration
5.7
34.3
101
180
A28
ICPC
Limited function/disability NOS
1.8
34.3
676
3991
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
34.2
602
3427
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.0
34.2
461
2378
J46
ICD-10 Finland
Status asthmaticus
3.1
33.7
197
658
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
33.7
2346
18608
BC1AD
NOMESCO Finland
CT of adrenal glands
7.2
33.6
83
117
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
33.6
538
2961
UKC02
NOMESCO Finland
Cystoscopy
1.7
33.6
764
4707
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.3
33.4
324
1446
2370A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct
+∞
33.3
32
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
33.2
1555
11431
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.7
32.8
230
863
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
32.7
533
2952
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
32.7
1502
10992
R03DA04
ATC
theophylline; systemic, rectal
2.4
32.7
283
1195
R55
ICD-10 Finland
Syncope and collapse
1.8
32.6
565
3195
N05BA12
ATC
alprazolam; oral
1.8
32.6
586
3356
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
32.5
302
1322
N06AB05
ATC
paroxetine; oral
2.1
32.3
396
1964
JN4BD
NOMESCO Finland
Extensive body CT
1.8
32.3
557
3146
A10AE04
ATC
insulin glargine; parenteral
1.9
32.3
508
2776
Z2446
NOMESCO Finland
Social worker
1.9
32.3
489
2638
H01CB03
ATC
lanreotide; parenteral
17.1
32.2
51
30
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
6.2
32.2
88
143
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
32.1
782
4907
R03AC12
ATC
salmeterol; inhalant
2.5
31.9
263
1082
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
318.3
31.9
32
*
-50
ICPC
Medication/prescr/renewal
2.5
31.8
261
1069
SPAT1216
SPAT
Assessment of functional ability
1.7
31.8
755
4709
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
31.7
1780
13535
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
31.7
750
4670
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
31.6
1714
12950
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.4
31.6
288
1250
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.2
31.3
347
1649
E23.1
ICD-10 Finland
Drug-induced hypopituitarism
+∞
31.3
30
*
2554A
ICD-9 Finland
Disorders of adrenal glands, Corticoadrenal insufficiency[MORBUS ADDISON PRIMARIUS]
+∞
31.3
30
*
2532A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]
+∞
31.3
30
*
2530A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]
+∞
31.3
30
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
31.2
477
2580
R01AD08
ATC
fluticasone; nasal
1.4
31.2
1645
12353
WX882
NOMESCO Finland
High dependency care
2.6
31.2
241
956
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.8
31.0
209
766
WZC30
NOMESCO Finland
Teaching
1.7
30.9
723
4487
N06AX26
ATC
vortioxetine; oral
2.1
30.9
372
1832
N04BC01
ATC
bromocriptine; oral
70.1
30.8
35
5
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
30.8
1646
12389
N06AX12
ATC
bupropion; oral
2.0
30.8
410
2104
A11CC03
ATC
alfacalcidol; systemic
3.2
30.7
168
537
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
30.5
482
2636
ZX114
NOMESCO Finland
Intramuscular
3.8
30.4
133
357
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
4.1
30.3
122
304
25390
ICD-8 Finland
Diseases of pituitary gland, Diabetes insipidus
+∞
30.2
29
*
V04CD01
ATC
metyrapone; oral
+∞
30.2
29
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
5.3
30.1
93
176
SPAT1310
SPAT
Counselling related to known health issue
1.4
30.1
1823
14033
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.7
30.1
208
774
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
30.1
278
1215
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
30.0
401
2062
A12BA01
ATC
potassium chloride; oral
2.7
30.0
217
831
S97
ICPC
Chronic ulcer skin
2.3
29.9
279
1224
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.8
29.8
508
2852
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.7
29.8
132
358
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
29.8
593
3507
T90
ICPC
Diabetes non-insulin dependent
1.5
29.8
1067
7382
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
11.3
29.7
56
50
T28
ICPC
Limited function/disability (T)
5.2
29.6
94
184
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
29.5
552
3198
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
29.4
552
3202
E87.6
ICD-10 Finland
Hypokalaemia
2.9
29.3
190
678
R52.2
ICD-10 Finland
Other chronic pain
2.6
29.3
224
886
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
29.2
530
3040
R03BA08
ATC
ciclesonide; inhalant
1.9
29.2
477
2642
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
3.9
29.1
123
320
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
29.0
331
1592
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
29.0
3133
26504
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
29.0
2794
23218
RD210
NOMESCO Finland
NA
2.9
28.9
181
634
J45.8
ICD-10 Finland
Mixed asthma
2.7
28.9
209
798
205
Kela drug reimbursment
Chronic hypertension
1.5
28.8
1213
8684
Z3226
NOMESCO Finland
Physiotherapist
1.5
28.8
1079
7531
N30.0
ICD-10 Finland
Acute cystitis
1.6
28.7
740
4711
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
28.7
2086
16552
E34.30
ICD-10 Finland
Short stature NOS
13.2
28.6
50
38
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
28.6
362
1822
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
28.5
571
3379
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
28.4
890
5959
R03BA01
ATC
beclometasone; inhalant
1.6
28.4
763
4910
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
28.2
385
1996
UDM02
NOMESCO Finland
Sinoscopy
3.1
28.1
158
515
8700/3-C74.9
ICD-O-3
Pheochromocytoma, NOS, of adrenal gland, NOS
+∞
28.1
27
*
25800
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Cushing's syndrome
+∞
28.1
27
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.7
28.1
204
781
J01DA01
ATC
[U] cefalexin; systemic
1.3
28.0
3615
31341
B01AB05
ATC
enoxaparin; parenteral
1.4
28.0
1500
11262
A04
ICPC
Weakness/tiredness general
1.6
27.8
730
4670
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
27.8
388
2029
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
27.5
318
1541
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.9
27.4
414
2227
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.3
27.4
267
1195
SPAT1240
SPAT
Therapeutic discussion
1.6
27.4
683
4309
E30.1
ICD-10 Finland
Precocious puberty
15.1
27.2
45
30
E66.9
ICD-10 Finland
Obesity, unspecified
2.5
27.2
224
923
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.4
27.1
241
1034
ZXE00
NOMESCO Finland
One hour or less
1.4
27.1
2305
18722
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
27.0
1277
9347
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
26.9
416
2256
WX723
NOMESCO Finland
CPAP therapy
2.5
26.9
218
890
N03AX11
ATC
topiramate; oral
2.7
26.8
192
730
M25.5
ICD-10 Finland
Pain in joint
1.4
26.7
1579
12052
Z00.0
ICD-10 Finland
General medical examination
1.5
26.7
1016
7106
SPAT1229
SPAT
Assessment of need for aid
1.9
26.7
385
2039
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.3
26.7
260
1166
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
10.5
26.6
52
50
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.9
26.6
436
2416
H02AB07
ATC
prednisone; oral
1.6
26.5
736
4771
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
26.3
586
3580
N05BE01
ATC
buspirone; oral
2.6
26.3
194
752
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
29.3
26.2
35
12
C08CA13
ATC
lercanidipine; oral
1.7
26.2
595
3653
J01FA06
ATC
roxithromycin; oral
1.3
26.2
2199
17793
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.8
26.2
177
651
N05AB03
ATC
perphenazine; systemic, rectal
2.4
26.2
229
974
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.5
26.1
204
817
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
4.1
26.1
103
253
E24.3
ICD-10 Finland
Ectopic ACTH syndrome
+∞
26.0
25
*
L01XX23
ATC
mitotane; oral
+∞
26.0
25
*
M05BX04
ATC
denosumab; parenteral
2.3
25.9
242
1063
A01AB09
ATC
miconazole; local oral
1.8
25.9
471
2699
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
25.9
270
1247
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
11.5
25.8
48
42
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
25.8
1279
9440
M01AH01
ATC
celecoxib; oral (coxibs)
1.5
25.7
897
6149
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
25.7
350
1813
SPAT1260
SPAT
Consultation of another employee
1.5
25.5
988
6926
Z71.8
ICD-10 Finland
Other specified counselling
1.4
25.5
1394
10477
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.1
25.5
287
1375
R96
ICPC
Asthma
1.8
25.4
472
2727
K59.1
ICD-10 Finland
Functional diarrhoea
2.1
25.4
284
1358
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
25.3
1983
15847
WX402
NOMESCO Finland
General anaesthesia
1.5
25.3
963
6731
R01AD09
ATC
mometasone; nasal
1.3
25.2
2614
21807
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.0
25.2
329
1675
P01AB01
ATC
metronidazole; oral, rectal
1.3
25.1
2166
17569
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
25.1
504
2980
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
25.0
425
2382
E27
ICD-10 Finland
Other disorders of adrenal gland
+∞
25.0
24
*
318
Kela drug reimbursment
Teriparatide
8.4
24.9
55
66
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
24.9
409
2267
H05AA02
ATC
teriparatide; parenteral
8.9
24.9
53
60
J01FA10
ATC
azithromycin; systemic
1.3
24.9
3533
30809
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.8
24.8
161
578
A12AA04
ATC
calcium carbonate; oral
3.5
24.8
117
336
R06AE07
ATC
cetirizine; oral
1.3
24.8
2545
21188
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.9
24.7
404
2237
ZXA10
NOMESCO Finland
Bilateral
1.5
24.6
973
6847
G03GA01
ATC
chorionic gonadotrophin; parenteral
2.3
24.6
239
1071
E26.0
ICD-10 Finland
Primary hyperaldosteronism
7.3
24.6
59
81
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.5
24.4
193
779
N05CF02
ATC
zolpidem; oral
1.5
24.3
945
6630
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
24.2
551
3380
C07AB02
ATC
metoprolol; systemic
1.5
24.2
924
6454
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
3.7
24.2
107
291
R06.5
ICD-10 Finland
Mouth breathing
1.7
24.2
499
2974
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
24.2
228
1008
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
24.1
1037
7429
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
24.1
545
3341
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.2
24.1
240
1089
N06AX03
ATC
mianserin; oral
2.2
24.0
260
1224
J01AA02
ATC
doxycycline; systemic
1.3
24.0
4441
40088
8370/3-C74.0
ICD-O-3
Adrenal cortical carcinoma of cortex of adrenal gland
+∞
24.0
23
*
25500
ICD-8 Finland
Diseases of adrenal glands, Aldosteronismus. Syndroma Conn
+∞
24.0
23
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.0
23.9
330
1717
N05AN01
ATC
lithium; oral
2.6
23.8
176
684
M48.0
ICD-10 Finland
Spinal stenosis
1.7
23.8
524
3187
Z31.5
ICD-10 Finland
Genetic counselling
2.0
23.8
333
1742
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
23.7
181
716
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
23.7
692
4540
L04AA06
ATC
mycophenolic acid; systemic
3.1
23.6
130
419
XG410
NOMESCO Finland
Flow-volume spirometry
2.2
23.6
249
1156
R35
ICD-10 Finland
Polyuria
2.0
23.6
322
1668
J01FA09
ATC
clarithromycin; systemic
1.4
23.6
1789
14187
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
23.6
2370
19622
K59.09
ICD-10 Finland
Constipation, unspecified
2.0
23.6
321
1661
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
23.4
1289
9680
N05AF03
ATC
chlorprothixene; systemic
2.5
23.4
182
726
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
23.4
677
4431
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
23.4
440
2553
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.8
23.3
156
571
C09CA06
ATC
candesartan; oral
1.4
23.2
1064
7715
C01CA24
ATC
epinephrine; parenteral
1.9
23.2
372
2046
E86
ICD-10 Finland
Volume depletion
3.0
23.1
137
465
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.2
23.1
238
1095
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
23.1
303
1548
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
23.1
1626
12739
M79.7
ICD-10 Finland
Fibromyalgia
2.4
23.0
194
810
XA800
NOMESCO Finland
Neuropsychological investigation
2.0
23.0
291
1462
Z2445
NOMESCO Finland
Psychologist
2.0
23.0
321
1679
2270A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Adrenal gland
+∞
22.9
22
*
25398
ICD-8 Finland
Diseases of pituitary gland, Alii definiti
+∞
22.9
22
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
22.9
640
4149
H53.2
ICD-10 Finland
Diplopia
2.6
22.9
174
688
L17
ICPC
Foot/toe symptom/complaint
1.4
22.9
1333
10105
E34.31
ICD-10 Finland
Short stature, prenatal disorder
14.7
22.9
38
26
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
5.6
22.8
67
121
R02
ICPC
Shortness of breath/dyspnoea
1.6
22.8
608
3898
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
22.7
502
3057
N03AX14
ATC
levetiracetam; systemic
2.5
22.7
181
732
WX002
NOMESCO Finland
Sedation and analgesia
1.5
22.7
981
7026
N06AG02
ATC
moclobemide; oral
2.1
22.7
255
1222
SPAT1255
SPAT
Intravenous administration of medicine
1.9
22.7
344
1853
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
22.6
605
3881
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.8
22.6
152
560
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.0
22.5
132
445
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.9
22.5
349
1897
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.0
22.5
302
1556
XLA10
NOMESCO Finland
NA
2.0
22.4
283
1423
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.1
22.4
126
413
XKD00
NOMESCO Finland
Uroflowmetry
1.6
22.4
659
4332
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.9
22.2
136
472
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
22.2
375
2100
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.2
22.2
120
383
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
22.1
728
4910
C10AA05
ATC
atorvastatin; oral
1.3
22.1
1676
13272
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
22.0
927
6602
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
22.0
335
1808
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
22.0
288
1471
25300
ICD-8 Finland
Diseases of pituitary gland, Aeromegalia
+∞
21.9
21
*
UDC00
NOMESCO Finland
Ear microscopy
1.8
21.9
407
2353
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
21.8
492
3012
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
21.8
681
4538
L03
ICPC
Low back symptom/complaint
1.4
21.8
1271
9628
N03AF01
ATC
carbamazepine; oral, rectal
2.0
21.7
279
1412
C09CA01
ATC
losartan; oral
1.4
21.6
1087
8013
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
21.6
406
2354
L04AX01
ATC
azathioprine; systemic
2.0
21.6
274
1381
R33
ICD-10 Finland
Retention of urine
1.9
21.5
333
1806
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
21.5
292
1511
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
21.4
1224
9237
R03BA02
ATC
budesonide; inhalant
1.5
21.4
956
6887
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
21.2
374
2125
F34.1
ICD-10 Finland
Dysthymia
2.2
21.2
222
1031
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
21.1
747
5122
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.7
21.1
94
259
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.8
21.1
137
493
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
21.0
788
5469
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.1
20.9
230
1089
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
5.8
20.9
59
102
25399
ICD-8 Finland
Diseases of pituitary gland, Other and unspecified
+∞
20.8
20
*
J01EA01
ATC
trimethoprim; systemic
1.4
20.8
1272
9705
A01
ICPC
Pain general/multiple sites
1.8
20.8
399
2327
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.1
20.7
243
1186
SPAT1312
SPAT
General health counselling
1.3
20.7
1862
15096
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
20.7
1429
11125
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
20.7
1169
8796
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.8
20.6
356
2009
N06AA10
ATC
nortriptyline; systemic
2.7
20.6
139
513
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
20.5
851
6034
R01AD12
ATC
fluticasone furoate; nasal
1.3
20.5
1703
13640
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.0
20.5
253
1261
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.2
20.5
205
934
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
20.5
706
4814
A03FA02
ATC
cisapride; oral, rectal
1.8
20.4
368
2103
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.1
20.4
227
1085
J45
ICD-10 Finland
Asthma
1.6
20.3
525
3332
J01CA04
ATC
amoxicillin; systemic
1.3
20.3
5062
46940
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.6
20.3
147
567
R03DC01
ATC
zafirlukast; oral
3.3
20.2
102
310
N18.8
ICD-10 Finland
Other chronic renal failure
2.7
20.2
143
544
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.5
20.2
95
274
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.2
20.1
106
333
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.2
20.1
205
942
ZY010
NOMESCO Finland
Hospital outpatient
1.8
20.0
345
1942
R60.9
ICD-10 Finland
Oedema, unspecified
2.1
20.0
238
1171
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
19.9
251
1262
M03BX02
ATC
tizanidine; oral
1.3
19.9
3491
30875
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.3
19.9
184
805
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.0
19.9
117
397
C10AC01
ATC
colestyramine; oral
2.5
19.8
153
610
R52.9
ICD-10 Finland
Pain, unspecified
1.7
19.8
442
2696
E22.88
ICD-10 Finland
Other hyperfunction of pituitary gland
+∞
19.8
19
*
2550A
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SDR CUSHING E HYPERPLASIA GLANDULAE SUPRARENALI]
+∞
19.8
19
*
25310
ICD-8 Finland
Diseases of pituitary gland, Panhypopituitarismus
+∞
19.8
19
*
I15.2
ICD-10 Finland
Hypertension secondary to endocrine disorders
15.3
19.7
32
21
R01AD01
ATC
beclometasone; nasal
1.5
19.7
814
5769
XF404
NOMESCO Finland
Ambulatory ECG
1.7
19.6
462
2861
N64.3
ICD-10 Finland
Galactorrhoea not associated with childbirth
6.8
19.6
49
72
G43.9
ICD-10 Finland
Migraine, unspecified
1.8
19.6
347
1971
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
19.6
787
5539
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
19.6
452
2785
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
29.0
19.6
26
9
P76
ICPC
Depressive disorder
1.8
19.6
368
2131
127
Kela drug reimbursment
Transplant complication
3.0
19.6
115
390
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
19.5
1008
7452
SPAT1325
SPAT
Vaccination
1.3
19.5
1822
14825
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
6.4
19.5
51
80
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.1
19.5
220
1057
I95.9
ICD-10 Finland
Hypotension, unspecified
3.8
19.4
82
216
E000001
ATC
NA
1.4
19.4
1147
8690
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
19.4
381
2240
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
19.4
317
1756
A10AE05
ATC
insulin detemir; parenteral
1.8
19.3
313
1727
A10BH01
ATC
sitagliptin; oral
1.7
19.3
414
2497
N03AF02
ATC
oxcarbazepine; oral
2.2
19.3
196
897
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
19.2
279
1482
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
19.2
471
2951
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.8
19.1
127
465
R63.1
ICD-10 Finland
Polydipsia
7.4
19.1
45
61
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.4
19.1
158
654
T82
ICPC
Obesity
2.1
19.1
219
1060
E87.5
ICD-10 Finland
Hyperkalaemia
3.5
19.0
89
256
S06.0
ICD-10 Finland
Concussion
1.6
19.0
575
3801
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
19.0
243
1228
R03AC13
ATC
formoterol; inhalant
2.0
18.9
247
1260
SPAT1234
SPAT
Support of social functional capacity
2.0
18.9
243
1233
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
18.9
288
1558
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
18.8
210
1002
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.7
18.8
133
506
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.6
18.8
136
524
E25.8
ICD-10 Finland
Other adrenogenital disorders
+∞
18.7
18
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.6
18.7
86
244
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.3
18.7
176
778
T29
ICPC
Endocr/metab/nutr sympt/compl other
2.9
18.7
114
396
N06AA12
ATC
doxepin; systemic
1.9
18.7
262
1374
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.6
18.6
139
545
K59.0
ICD-10 Finland
Constipation
1.9
18.6
286
1551
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
18.6
434
2681
E89.39
ICD-10 Finland
Postprocedural hypopituitarism, other or several procedures
190.3
18.5
19
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.9
18.5
292
1596
WX892
NOMESCO Finland
Monitored bed care
1.7
18.5
384
2296
N04AA02
ATC
biperiden; systemic
2.7
18.4
124
459
D07AC01
ATC
betamethasone; topical
1.3
18.4
1732
14087
A07AA09
ATC
vancomycin; oral
3.8
18.4
78
207
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.6
18.3
554
3658
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
18.3
897
6560
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.0
18.3
105
350
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
2.1
18.2
206
991
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
18.1
828
5977
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.6
18.1
500
3230
R07.3
ICD-10 Finland
Other chest pain
1.6
18.1
451
2836
C10AA01
ATC
simvastatin; oral
1.3
18.1
1814
14879
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
17.9
3968
35878
R41.0
ICD-10 Finland
Disorientation, unspecified
2.5
17.8
138
553
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.4
17.8
157
674
N06AX22
ATC
agomelatine; oral
2.5
17.8
141
572
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.7
17.8
126
479
2550X
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING NUD]
+∞
17.7
17
*
A02BA04
ATC
nizatidine; systemic
1.7
17.7
358
2124
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
17.6
707
4973
WX780
NOMESCO Finland
Remote monitoring CPAP
2.1
17.6
202
979
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
17.6
1563
12598
M01AE02
ATC
naproxen; oral, rectal
1.3
17.5
3297
29209
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
17.5
219
1098
8700/3-C74.1
ICD-O-3
Pheochromocytoma, NOS, of medulla of adrenal gland
180.3
17.5
18
*
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
17.4
1345
10616
F32.1
ICD-10 Finland
Moderate depressive episode
1.8
17.4
316
1812
J05AB01
ATC
aciclovir; systemic
1.4
17.3
1073
8177
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
17.3
245
1290
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
17.3
297
1671
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
4.0
17.3
69
174
S10
ICPC
Boil/carbuncle
1.8
17.3
284
1578
SPAT1097
SPAT
Recording of ECG
1.5
17.1
670
4684
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.1
17.1
189
901
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
17.1
254
1362
XQ800
NOMESCO Finland
Prick test
1.6
17.1
449
2863
C08CA05
ATC
nifedipine; systemic
1.8
17.1
290
1626
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
17.1
537
3579
M01AH02
ATC
rofecoxib; oral
1.5
17.1
597
4078
E000003
ATC
NA
1.9
17.1
259
1399
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.9
17.0
239
1255
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
17.0
2059
17285
N06AB08
ATC
fluvoxamine; oral
2.3
17.0
159
702
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
17.0
3137
27695
E29.9
ICD-10 Finland
Testicular dysfunction, unspecified
13.2
16.9
29
22
N19
ICD-10 Finland
Unspecified kidney failure
2.4
16.9
145
615
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
16.9
231
1199
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
16.9
521
3457
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
16.8
1463
11740
N05AH02
ATC
clozapine; systemic
2.5
16.8
132
535
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
16.8
646
4504
106
Kela drug reimbursment
Hypoparathyroidism
6.1
16.7
45
74
G04BD04
ATC
oxybutynin; oral, transdermal
1.9
16.7
248
1326
AA4DM
NOMESCO Finland
Very extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
16.7
16
*
2550B
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERFUNCTIO GLAN SUPRARENALI]
+∞
16.7
16
*
P01
ICPC
Feeling anxious/nervous/tense
1.5
16.6
625
4335
M02AA07
ATC
piroxicam; topical
1.3
16.6
1749
14411
R51
ICD-10 Finland
Headache
1.8
16.6
291
1653
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.2
16.5
177
832
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.1
16.5
191
929
D35.59
ICD-10 Finland
Other paragangliom
170.2
16.5
17
*
D07AA02
ATC
hydrocortisone; topical
1.4
16.4
769
5570
G43.3
ICD-10 Finland
Complicated migraine
2.8
16.4
105
375
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.4
16.4
141
598
L04AD01
ATC
ciclosporin; systemic
2.5
16.4
128
516
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.8
16.4
274
1530
M79.1
ICD-10 Finland
Myalgia
1.5
16.3
653
4584
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
16.3
474
3102
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
16.3
3084
27251
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.5
16.3
131
537
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.0
16.3
93
309
ZXA05
NOMESCO Finland
Left side
1.3
16.3
1199
9388
R5599
NOMESCO Finland
Other rehabilitation service
2.2
16.2
163
746
K76.9
ICD-10 Finland
Liver disease, unspecified
3.1
16.2
90
295
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
5.9
16.2
45
77
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
16.2
144
622
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.1
16.2
90
296
R03AC03
ATC
terbutaline; inhalant
1.4
16.2
729
5247
JN4AD
NOMESCO Finland
Body CT examination
1.7
16.1
333
1987
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.3
16.1
154
689
BF20A
NOMESCO Finland
NA
30.1
16.1
21
7
R4180
NOMESCO Finland
Podiatric therapy
3.7
16.1
70
191
SPAT1243
SPAT
Psychiatric/psychological examination
2.1
16.1
188
920
K02.1
ICD-10 Finland
Caries of dentine
1.2
16.1
3371
30110
C08DA01
ATC
verapamil; systemic
2.0
16.0
195
970
XW000
NOMESCO Finland
Bone marrow biopsy
2.0
16.0
203
1024
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
4.4
16.0
58
134
C09AA02
ATC
enalapril; systemic
1.4
16.0
826
6095
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.6
16.0
119
468
C09AA05
ATC
ramipril; oral
1.4
15.9
1009
7707
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
15.9
343
2073
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.2
15.9
157
711
N97.0
ICD-10 Finland
Female infertility associated with anovulation
2.5
15.8
123
496
A99
ICPC
Disease/condition unspecnature/site
1.6
15.8
390
2447
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.3
15.8
143
621
N06AA06
ATC
trimipramine; systemic
2.4
15.8
138
591
A04AA01
ATC
ondansetron; systemic, rectal
1.7
15.8
335
2016
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.7
15.7
303
1769
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
2.7
15.7
107
400
R06AE09
ATC
levocetirizine; oral
1.4
15.7
796
5849
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.7
15.7
329
1973
F61.0
ICD-10 Finland
Mixed personality disorders
2.6
15.7
114
443
M81.4
ICD-10 Finland
Drug-induced osteoporosis
7.3
15.7
37
51
Y0099
ICD-8 Finland
Investigation of endocrine system and metabolism
5.9
15.6
43
73
BCA41
NOMESCO Finland
Endoscopic bilateral adrenalectomy
+∞
15.6
15
*
25599
ICD-8 Finland
Diseases of adrenal glands, Other and unspecified
+∞
15.6
15
*
AA4AD
NOMESCO Finland
CT of sella turcica
+∞
15.6
15
*
R06AX22
ATC
ebastine; oral
1.4
15.6
879
6583
C08CA02
ATC
felodipine; oral
1.6
15.6
371
2306
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.1
15.6
170
807
E83.50
ICD-10 Finland
Hypercalcemia
3.6
15.5
70
197
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
15.5
516
3484
Z94.0
ICD-10 Finland
Kidney transplant status
3.1
15.5
83
266
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.0
15.5
210
1090
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
6.6
15.5
39
59
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
2.8
15.4
101
369
L29
ICPC
Musculoskeletal sympt/complt other
1.6
15.4
368
2288
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
2.8
15.4
100
363
J01CA08
ATC
pivmecillinam; oral
1.3
15.4
2044
17302
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
15.3
1071
8306
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.0
15.3
187
931
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.3
15.3
137
594
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.9
15.3
94
330
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.8
15.2
98
352
R4190
NOMESCO Finland
Nutritional therapy
1.9
15.2
234
1270
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.9
15.2
90
309
R03BB01
ATC
ipratropium bromide; inhalant
2.1
15.2
170
818
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.5
15.2
121
495
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.8
15.1
98
355
P03
ICPC
Feeling depressed
1.5
15.1
520
3534
S29
ICPC
Skin symptom/complaint other
1.4
15.1
824
6133
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.5
15.1
117
471
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.2
15.1
77
239
SPAT1252
SPAT
Overall medication plan or its review
1.7
15.1
314
1878
TKC20
NOMESCO Finland
Catheterisation of bladder
1.7
15.0
304
1804
C02AC05
ATC
moxonidine; oral
2.0
15.0
200
1030
D35.9
ICD-10 Finland
Benign neoplasm: Endocrine gland, unspecified
45.0
15.0
18
*
R1250
NOMESCO Finland
Evaluation of functional capability
2.5
15.0
120
491
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
15.0
389
2471
T73
ICPC
Neoplasm endocrine other/unspecified
11.8
15.0
27
23
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.3
15.0
132
568
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.8
15.0
273
1569
N04BC05
ATC
pramipexole; oral
1.7
15.0
320
1930
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.7
14.9
712
9408
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.8
14.9
262
1489
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
14.9
333
2032
602
Kela drug reimbursment
Children's severe malnutrition
3.8
14.9
63
168
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.6
14.9
372
2341
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
14.9
311
1863
L04AA01
ATC
[U] ciclosporin; systemic
2.8
14.9
93
331
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
14.9
455
3013
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.9
14.8
92
325
SPAT1211
SPAT
Application of soft bandage
1.5
14.8
464
3088
D07AC13
ATC
mometasone; topical
1.3
14.8
1472
12002
-1
NOMESCO Finland
NA
1.3
14.8
1962
16581
G04CA01
ATC
alfuzosin; oral
1.5
14.8
456
3022
N91.2
ICD-10 Finland
Amenorrhoea, unspecified
4.7
14.8
49
104
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
3.7
14.7
64
175
UJD02
NOMESCO Finland
Gastroscopy
1.9
14.7
230
1258
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.6
14.7
344
2130
TK800
NOMESCO Finland
Hemodialysis
2.5
14.6
117
479
A10BJ02
ATC
liraglutide; parenteral
2.4
14.6
121
506
2533A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Pituitary dwarfism[NANISMUS HYPOPHYSARIUS]
+∞
14.6
14
*
D352, E221
ICD-10 Finland
NA
+∞
14.6
14
*
6116A
ICD-9 Finland
Other disorders of breast, Galactorrhoea not associated with childbirth
+∞
14.6
14
*
Q96.3
ICD-10 Finland
Mosaicism, 45,X/46,XX or XY
+∞
14.6
14
*
M03BX01
ATC
baclofen; systemic
2.7
14.6
100
377
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.4
14.6
126
537
E31.00
ICD-10 Finland
APECED syndrome
80.2
14.6
16
*
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
3.9
14.6
59
152
C10AX09
ATC
ezetimibe; oral
1.6
14.6
438
2887
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.7
14.5
292
1729
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
2.7
14.5
96
354
WZA90
NOMESCO Finland
Other doctors statement
1.3
14.5
1277
10239
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.9
14.5
58
148
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
14.5
117
483
J32.4
ICD-10 Finland
Chronic pansinusitis
3.0
14.4
84
285
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
14.4
835
6275
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
14.4
813
6083
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
14.4
4230
38944
N06AX18
ATC
reboxetine; oral
3.1
14.4
79
258
N06BA04
ATC
methylphenidate; oral
2.1
14.4
167
816
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.3
14.4
132
581
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.4
14.4
116
478
M01AG02
ATC
tolfenamic acid; oral, rectal
1.4
14.3
783
5829
L86
ICPC
Back syndrome with radiating pain
1.8
14.3
269
1561
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
14.3
267
1545
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
14.3
544
3781
E28.3
ICD-10 Finland
Primary ovarian failure
6.6
14.3
36
55
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
14.2
308
1864
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
14.2
206
1098
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.4
14.1
123
526
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
14.1
359
2273
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
14.1
1444
11809
L01
ICPC
Neck symptom/complaint
1.4
14.0
680
4954
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
3.0
14.0
81
273
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
7.0
14.0
34
49
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
14.0
2057
17568
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.7
14.0
97
368
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.5
14.0
522
3612
SPAT1139
SPAT
Nutrition survey
2.0
14.0
170
847
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
14.0
2734
24097
N05AF01
ATC
flupentixol; systemic
2.7
13.9
92
339
A02BC04
ATC
rabeprazole; oral
1.6
13.9
413
2712
WX290
NOMESCO Finland
Other blockade of nerve
1.2
13.9
2567
22479
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
13.9
1068
8392
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.5
13.9
459
3095
P06
ICPC
Sleep disturbance
1.5
13.9
495
3390
D02AE01
ATC
carbamide; topical
1.6
13.9
342
2147
J01DA06
ATC
[U] cefuroxime; systemic
1.4
13.8
726
5366
N05AD01
ATC
haloperidol; systemic
2.1
13.8
150
710
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.5
13.8
63
180
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.1
13.8
152
725
J02AC02
ATC
itraconazole; systemic
1.4
13.8
877
6694
V03AE01
ATC
polystyrene sulfonate; oral
3.3
13.8
69
212
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.0
13.7
181
928
U04
ICPC
Incontinence urine
1.9
13.7
194
1025
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
13.7
511
3538
TQW80
NOMESCO Finland
Local dermatologic skincare
2.2
13.6
131
588
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
13.6
237
1343
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
3.7
13.6
59
162
A02BX02
ATC
sucralfate; oral
2.0
13.6
176
900
E24
ICD-10 Finland
Cushing syndrome
75.2
13.6
15
*
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.3
13.6
122
530
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.5
13.5
449
3030
E25.0
ICD-10 Finland
Congenital adrenogenital disorders associated with enzyme deficiency
+∞
13.5
13
*
BC5AQ
NOMESCO Finland
Chromaffine tissue SPECT with low dose CT
+∞
13.5
13
*
N97.9
ICD-10 Finland
Female infertility, unspecified
1.7
13.5
265
1557
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
13.5
340
2147
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.3
13.5
128
573
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
13.5
3287
29591
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.6
13.5
96
369
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
9.3
13.4
27
29
J31.0
ICD-10 Finland
Chronic rhinitis
1.5
13.4
401
2641
C07AG02
ATC
carvedilol; oral
1.8
13.4
239
1365
D75.1
ICD-10 Finland
Secondary polycythaemia
4.5
13.4
46
102
ZY000
NOMESCO Finland
Hospital inpatient
2.6
13.4
95
364
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.1
13.4
149
715
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.3
13.3
116
498
R03AK11
ATC
formoterol and fluticasone; inhalant
2.2
13.3
132
602
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
25.7
13.3
18
7
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
4.2
13.3
50
121
R13
ICD-10 Finland
Dysphagia
1.7
13.3
285
1720
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.7
13.3
87
319
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.2
13.3
134
617
K03.66
ICD-10 Finland
Tooth plaque
1.6
13.2
370
2400
A10BJ06
ATC
semaglutide; parenteral
2.1
13.2
155
760
OAB72
NOMESCO Finland
Weight control and weight loss guidance
4.4
13.2
47
108
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.3
13.1
65
198
K29.7
ICD-10 Finland
Gastritis, unspecified
2.0
13.1
166
840
H47.4
ICD-10 Finland
Disorders of optic chiasm
40.1
13.1
16
*
JAH01
NOMESCO Finland
Laparoscopy
1.8
13.1
231
1314
XF402
NOMESCO Finland
ECG with work load test
1.5
13.1
477
3284
M02AA10
ATC
ketoprofen; topical
1.4
13.1
723
5389
R01AD05
ATC
budesonide; nasal
1.5
13.1
390
2569
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.1
13.1
147
708
H26.3
ICD-10 Finland
Drug-induced cataract
4.2
13.0
48
114
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
2.2
13.0
135
630
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.6
13.0
309
1920
P29
ICPC
Psychological sympt/compl other
1.6
13.0
319
2002
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
3.4
13.0
62
184
J47
ICD-10 Finland
Bronchiectasis
2.7
13.0
90
342
M54.2
ICD-10 Finland
Cervicalgia
1.6
13.0
341
2178
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
12.9
323
2035
R25.1
ICD-10 Finland
Tremor, unspecified
2.2
12.9
134
624
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.1
12.9
153
754
RJ410
NOMESCO Finland
NA
5.5
12.9
37
67
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.5
12.9
517
3629
R05FB02
ATC
cough suppressants and expectorants
1.2
12.9
1815
15396
XF602
NOMESCO Finland
Bloodpressure monitoring
3.1
12.9
71
234
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
12.9
377
2471
G72.8
ICD-10 Finland
Other specified myopathies
3.0
12.9
74
249
N17
ICPC
Vertigo/dizziness
1.5
12.9
501
3495
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.8
12.8
234
1348
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
6.9
12.8
31
45
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.5
12.8
424
2860
R4110
NOMESCO Finland
Physiotherapy
1.3
12.8
1339
10966
G03GA02
ATC
human menopausal gonadotrophin; parenteral
2.2
12.8
126
576
K30
ICD-10 Finland
Functional dyspepsia
1.5
12.7
498
3477
RS221
NOMESCO Finland
NA
2.5
12.7
97
390
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.0
12.7
158
794
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.5
12.7
456
3131
WX722
NOMESCO Finland
PEEP
1.8
12.7
216
1218
R05
ICD-10 Finland
Cough
1.3
12.6
966
7575
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.6
12.6
302
1880
Z01.2
ICD-10 Finland
Dental examination
1.2
12.6
2383
20856
N29
ICPC
Neurological sympt/complt other
2.4
12.6
105
442
2159
FHL
Other measure in this category
69.9
12.6
14
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.1
12.5
66
211
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.3
12.5
118
525
SPAT1053
SPAT
Memory test
1.4
12.5
515
3636
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
5.0
12.5
39
78
N48.4
ICD-10 Finland
Impotence of organic origin
2.4
12.5
102
425
AA400
NOMESCO Finland
Electroconvulsive therapy
3.2
12.5
65
206
2559X
ICD-9 Finland
Disorders of adrenal glands, Unspecified disorder of adrenal glands
+∞
12.5
12
*
9500/3-C74.1
ICD-O-3
Neuroblastoma, NOS, of medulla of adrenal gland
+∞
12.5
12
*
AA4BM
NOMESCO Finland
MRI examination of sella turcica with 3 Tesla magnet
+∞
12.5
12
*
J01MA01
ATC
ofloxacin; systemic
1.5
12.5
374
2464
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
12.5
267
1611
C03AA03
ATC
hydrochlorothiazide; oral
1.5
12.4
384
2550
G04CA02
ATC
tamsulosin; oral
1.3
12.4
809
6192
DPA30
NOMESCO Finland
Sphenotomy
4.6
12.4
42
92
137
Kela drug reimbursment
Uraemia requiring dialysis
3.4
12.4
58
170
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.6
12.4
333
2140
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
12.3
624
4580
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
3.6
12.3
55
155
A10BK03
ATC
empagliflozin; oral
1.6
12.3
304
1911
M01AB55
ATC
diclofenac, combinations; oral
1.6
12.3
289
1791
C10AA07
ATC
rosuvastatin; oral
1.3
12.3
1014
8035
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.9
12.3
182
976
F45.0
ICD-10 Finland
Somatization disorder
4.8
12.3
40
84
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
3.6
12.2
54
151
N46
ICD-10 Finland
Male infertility
2.8
12.2
76
270
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
12.2
1204
9775
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
12.2
2079
17985
G93.2
ICD-10 Finland
Benign intracranial hypertension
6.2
12.2
32
52
EBA10
NOMESCO Finland
Surgical removal of tooth
1.4
12.2
676
5039
SPAT1360
SPAT
Extensive global examination
1.6
12.2
345
2244
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.5
12.2
90
356
E03
ICD-10 Finland
Other hypothyroidism
1.7
12.2
263
1595
P01BA02
ATC
hydroxychloroquine; oral
1.5
12.2
378
2513
A07DA03
ATC
loperamide; oral
2.0
12.2
161
832
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
2.1
12.2
139
678
E30.8
ICD-10 Finland
Other disorders of puberty
15.9
12.1
19
12
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.6
12.1
316
2016
B03XA02
ATC
darbepoetin alfa; parenteral
2.6
12.1
88
344
-55
ICPC
Local injection/infiltration
4.1
12.1
46
113
R32
ICD-10 Finland
Unspecified urinary incontinence
2.2
12.1
126
590
Z00.8
ICD-10 Finland
Other general examinations
1.6
12.1
354
2320
A01AB04
ATC
amphotericin B; local oral
1.8
12.1
218
1253
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.4
12.0
96
396
N05AE04
ATC
ziprasidone; systemic
3.7
12.0
52
143
XG466
NOMESCO Finland
Sleep oxymetry
2.0
12.0
157
805
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
12.0
361
2384
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
11.0
12.0
22
20
J01FA15
ATC
telithromycin; oral
1.5
12.0
491
3461
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.1
12.0
137
667
F60.5
ICD-10 Finland
Anankastic personality disorder
3.0
12.0
67
224
-69
ICPC
Other reason for encounter NEC
1.9
12.0
185
1009
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.8
11.9
210
1198
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.8
11.9
206
1167
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
11.9
1387
11489
N07BC02
ATC
methadone; systemic
6.2
11.9
31
50
E66
ICD-10 Finland
Obesity
1.7
11.9
222
1287
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.1
11.9
129
612
RS220
NOMESCO Finland
NA
2.5
11.9
93
378
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.2
11.9
114
515
L16
ICPC
Ankle symptom/complaint
1.4
11.8
510
3635
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
11.8
305
1939
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.7
11.8
619
8090
P20
ICPC
Memory disturbance
1.5
11.8
415
2836
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.7
11.8
247
1482
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
3.5
11.8
54
156
D86.0
ICD-10 Finland
Sarcoidosis of lung
2.9
11.7
70
244
F83
ICD-10 Finland
Mixed specific developmental disorders
2.8
11.7
73
261
F60.9
ICD-10 Finland
Personality disorder, unspecified
2.5
11.7
89
358
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.6
11.7
51
142
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.5
11.6
363
2418
D07AD01
ATC
clobetasol; topical
1.4
11.6
697
5261
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.8
11.6
196
1103
H57.1
ICD-10 Finland
Ocular pain
1.9
11.6
171
919
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.7
11.6
242
1453
XJH00
NOMESCO Finland
Transanal ultrasonography
1.7
11.6
228
1346
N02AC04
ATC
dextropropoxyphene; oral
2.0
11.6
150
770
B01AC04
ATC
clopidogrel; oral
1.4
11.6
570
4164
R04.0
ICD-10 Finland
Epistaxis
1.6
11.6
302
1927
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.7
11.5
239
1431
M05BA07
ATC
risedronic acid; oral
2.0
11.5
134
660
M81.8
ICD-10 Finland
Other osteoporosis
4.0
11.5
45
114
B01AA03
ATC
warfarin; systemic
1.3
11.5
751
5752
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
7.1
11.5
27
38
Q96.8
ICD-10 Finland
Other variants of Turner syndrome
+∞
11.5
11
*
Q96.0
ICD-10 Finland
Karyotype 45,X
+∞
11.5
11
*
25508
ICD-8 Finland
Diseases of adrenal glands, Hyperfunctio adrenocorticalis alia
+∞
11.5
11
*
BC5AN
NOMESCO Finland
Chromaffine and adrenergic tissue isotope imaging (MIBG)
120.1
11.4
12
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
11.4
118
549
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
2.5
11.4
90
367
T89
ICPC
Diabetes insulin dependent
1.7
11.4
212
1233
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
5.0
11.3
35
70
E000002
ATC
NA
1.4
11.3
605
4485
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.9
11.3
166
891
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.7
11.3
77
292
WX213
NOMESCO Finland
Lower leg blockade
3.5
11.3
51
146
NXL00
NOMESCO Finland
Biopsy of muscle
6.0
11.3
30
50
N06AX05
ATC
trazodone; oral
2.1
11.3
130
637
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
2.8
11.2
72
263
40199
ICD-8 Finland
Essential benign hypertension
2.6
11.2
77
293
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.7
11.2
250
1529
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.7
11.2
76
287
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
11.2
1065
8599
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
11.2
515
3714
U02
ICPC
Urinary frequency/urgency
1.4
11.2
586
4325
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.4
11.2
621
4632
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
1.9
11.2
165
889
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.8
11.1
195
1109
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
4.1
11.1
42
103
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.3
11.1
55
169
A03CA02
ATC
clidinium and psycholeptics; oral
1.7
11.1
244
1486
GD1AD
NOMESCO Finland
Thorax CT examination
1.8
11.1
182
1016
A02BB01
ATC
misoprostol; oral
4.3
11.1
40
94
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
11.1
1109
9012
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
11.1
848
6645
WX725
NOMESCO Finland
Noninvasive ventilation
1.7
11.0
205
1188
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.2
11.0
57
181
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
3.2
11.0
55
171
SBB10
NOMESCO Finland
Teeth copy
1.5
11.0
413
2863
E21.5
ICD-10 Finland
Disorder of parathyroid gland, unspecified
13.9
10.9
18
13
N75
ICPC
Benign neoplasm nervous system
13.9
10.9
18
13
K92.1
ICD-10 Finland
Melaena
1.8
10.9
199
1149
E21.0
ICD-10 Finland
Primary hyperparathyroidism
2.7
10.9
70
256
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
2.8
10.9
66
233
M01AE51
ATC
ibuprofen, combinations; systemic
2.5
10.9
81
322
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.3
10.9
96
416
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.2
10.9
107
489
K07.60
ICD-10 Finland
Snapping jaw
1.6
10.9
253
1568
N06AA04
ATC
clomipramine; systemic
2.4
10.9
87
360
D01AE15
ATC
terbinafine; topical
1.6
10.8
299
1933
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
3.1
10.8
58
189
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.5
10.8
81
324
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.5
10.8
81
324
A06AC51
ATC
ispaghula, combinations; systemic
1.7
10.8
226
1359
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
5.5
10.8
31
57
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.9
10.8
146
762
R06AX13
ATC
loratadine; oral
1.3
10.8
775
6014
N25.1
ICD-10 Finland
Nephrogenic diabetes insipidus
15.5
10.8
17
11
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.6
10.8
259
1618
B02.9
ICD-10 Finland
Zoster without complication
1.7
10.8
236
1439
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.1
10.7
114
540
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.3
10.7
53
163
RS222
NOMESCO Finland
NA
2.5
10.7
83
337
E66.0
ICD-10 Finland
Obesity due to excess calories
3.0
10.7
59
196
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.6
10.7
310
2030
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
10.7
767
5955
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.8
10.7
182
1029
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.5
10.7
398
2753
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
4.7
10.7
35
75
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.5
10.7
385
2648
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.0
10.7
127
630
XKC03
NOMESCO Finland
Water cystometry
2.0
10.7
136
694
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
10.7
2233
19653
A29
ICPC
General symptom/complaint other
1.4
10.6
495
3576
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
4.0
10.6
41
103
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.1
10.6
122
595
E89.31
ICD-10 Finland
Postirradiation hypopituitarism
60.0
10.6
12
*
D35.50
ICD-10 Finland
Carotid body
60.0
10.6
12
*
P99
ICPC
Psychological disorders other
1.9
10.6
152
809
L68.0
ICD-10 Finland
Hirsutism
3.7
10.6
45
123
R52.1
ICD-10 Finland
Chronic intractable pain
3.1
10.6
57
187
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.8
10.5
186
1061
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.4
10.5
626
4721
NF3AA
NOMESCO Finland
Femur X-ray examination
2.4
10.5
86
361
N28
ICPC
Limited function/disability (N)
2.7
10.5
71
268
Y08
ICPC
Sexual function sympt/compl male
4.7
10.5
34
72
J05AB11
ATC
valaciclovir; oral
1.4
10.5
612
4599
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.3
10.5
96
424
N05AA01
ATC
chlorpromazine; systemic, rectal
2.5
10.5
78
311
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.5
10.5
81
329
B01AB10
ATC
tinzaparin; parenteral
1.6
10.4
287
1856
P72
ICPC
Schizophrenia
2.2
10.4
101
457
T86
ICPC
Hypothyroidism/myxoedema
1.8
10.4
172
962
D35.3
ICD-10 Finland
Benign neoplasm: Craniopharyngeal duct
110.1
10.4
11
*
BF10A
NOMESCO Finland
NA
110.1
10.4
11
*
E31.08
ICD-10 Finland
Autoimmune polyglandular failure
110.1
10.4
11
*
25311
ICD-8 Finland
Diseases of pituitary gland, Hypopituitarismus partialis
+∞
10.4
10
*
25598
ICD-8 Finland
Diseases of adrenal glands, Alii definiti
+∞
10.4
10
*
25502
ICD-8 Finland
Diseases of adrenal glands, Virilismus adrenocorticalis
+∞
10.4
10
*
25319
ICD-8 Finland
Diseases of pituitary gland, Hypopituitarismus alia sive NUD
+∞
10.4
10
*
E24.4
ICD-10 Finland
Alcohol-induced pseudo-Cushing syndrome
+∞
10.4
10
*
M14.5*E22.0
ICD-10 Finland
Arthropathy associated with acromegaly
+∞
10.4
10
*
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.0
10.4
123
609
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.5
10.4
314
2077
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.5
10.4
317
2103
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
3.4
10.4
48
141
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.1
10.4
111
528
A41.8
ICD-10 Finland
Other specified sepsis
2.5
10.4
77
306
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
3.5
10.3
47
136
SPAT1307
SPAT
Psychosocial counselling and guidance
1.5
10.3
355
2418
R89.1
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, abnormal level of hormones
12.0
10.3
18
15
R52.0
ICD-10 Finland
Acute pain
1.9
10.3
152
819
RD211
NOMESCO Finland
NA
1.7
10.3
212
1269
M04AA01
ATC
allopurinol; systemic
1.4
10.3
471
3393
R06.2
ICD-10 Finland
Wheezing
1.7
10.3
217
1307
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.6
10.3
73
283
T78.4
ICD-10 Finland
Allergy, unspecified
1.6
10.3
242
1503
R04
ICPC
Breathing problem other
1.8
10.3
165
916
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.9
10.2
141
740
BC00A
NOMESCO Finland
NA
10.6
10.2
19
18
M01AX17
ATC
nimesulide; oral
1.3
10.2
1070
8732
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.8
10.2
65
237
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.1
10.2
110
525
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.2
10.2
97
437
R00.2
ICD-10 Finland
Palpitations
1.5
10.2
328
2198
G91.1
ICD-10 Finland
Obstructive hydrocephalus
4.7
10.2
33
70
R62.0
ICD-10 Finland
Delayed milestone
2.7
10.2
69
261
G44.0
ICD-10 Finland
Cluster headache syndrome
2.7
10.2
66
244
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
10.2
322
2151
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
10.2
334
2252
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.0
10.2
132
678
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.7
10.1
295
4237
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
10.1
677
5196
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
5.4
10.1
29
54
L14
ICPC
Leg/thigh symptom/complaint
1.5
10.1
325
2180
321
Kela drug reimbursment
Paricalcitol and cinacalcet
4.7
10.1
33
71
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.2
10.1
102
475
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
6.9
10.0
24
35
M43.1
ICD-10 Finland
Spondylolisthesis
1.8
10.0
167
938
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.7
10.0
185
1071
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
11.3
10.0
18
16
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
3.7
10.0
42
114
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
10.0
290
1901
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.4
10.0
47
140
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.6
10.0
72
283
F40.1
ICD-10 Finland
Social phobias
1.9
10.0
133
692
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
14.6
10.0
16
11
E000006
ATC
NA
1.5
10.0
327
2204
ZXA00
NOMESCO Finland
Right side
1.2
10.0
1222
10162
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.2
10.0
98
449
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
3.3
9.9
48
146
I95.1
ICD-10 Finland
Orthostatic hypotension
2.0
9.9
120
602
SPAT1167
SPAT
Insertion of urinary catheter
2.0
9.9
120
602
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
9.9
1812
15717
R15
ICD-10 Finland
Faecal incontinence
2.1
9.9
108
518
NF1DA
NOMESCO Finland
X-ray of hips
2.2
9.9
98
451
K90
ICPC
Stroke/cerebrovascular accident
2.2
9.9
100
463
D11
ICPC
Diarrhoea
1.4
9.9
577
4335
H26.2
ICD-10 Finland
Complicated cataract
2.6
9.9
68
261
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
1.9
9.9
150
817
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.2
9.9
95
432
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
2.8
9.9
59
208
F45.39
ICD-10 Finland
Somatoform autonomic dysfunction multiple or indeterminate organs
16.7
9.9
15
9
BC1BD
NOMESCO Finland
Extensive CT of adrenal glands
12.2
9.8
17
14
R49.08
ICD-10 Finland
Other specified dysphonia
2.2
9.8
100
467
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
2.9
9.8
58
203
C05AA08
ATC
fluocortolone; rectal, topical
1.3
9.8
651
4994
-44
ICPC
Preventive immunization/medic
1.5
9.8
358
2470
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
4.4
9.8
34
78
N62
ICD-10 Finland
Hypertrophy of breast
1.7
9.8
197
1176
B37.08
ICD-10 Finland
Other candidal stomatitis
3.5
9.7
43
122
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.9
9.7
143
769
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
9.5
9.7
19
20
E26.9
ICD-10 Finland
Hyperaldosteronism, unspecified
9.5
9.7
19
20
SPAT1131
SPAT
Colonoscopy
1.9
9.7
139
741
SPAT1377
SPAT
Polysomnography
1.8
9.7
155
861
K08.3
ICD-10 Finland
Retained dental root
1.5
9.7
303
2022
J34.2
ICD-10 Finland
Deviated nasal septum
1.6
9.7
247
1569
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
2.8
9.7
61
221
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.1
9.7
108
523
R60.1
ICD-10 Finland
Generalized oedema
3.5
9.7
43
123
L02AE02
ATC
leuprorelin; implant, parenteral
1.7
9.6
176
1018
WW200
NOMESCO Finland
Immunization
1.9
9.6
142
766
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.5
9.6
72
287
G72.9
ICD-10 Finland
Myopathy, unspecified
3.4
9.6
45
134
A12AA06
ATC
calcium lactate gluconate; oral
7.8
9.6
21
27
R31
ICD-10 Finland
Unspecified haematuria
1.5
9.6
367
2558
M54.3
ICD-10 Finland
Sciatica
1.6
9.6
257
1654
AN1
HP
Coronary angiography
1.4
9.6
424
3037
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.0
9.5
125
645
S21
ICPC
Skin texture symptom/complaint
1.4
9.5
556
4178
WX730
NOMESCO Finland
Conventional respirator
2.3
9.5
82
354
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.8
9.5
159
895
49300
ICD-8 Finland
Asthma, bronchiale
2.0
9.5
110
542
B81
ICPC
Anaemia vit B12/folate deficiency
1.8
9.5
149
819
G03DA04
ATC
progesterone; systemic, rectal, vaginal
1.8
9.5
159
896
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
9.5
411
2933
D84.18
ICD-10 Finland
Other specified defect in the complement system
9.1
9.5
19
21
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.7
9.5
338
4690
B03XA01
ATC
erythropoietin; parenteral
3.1
9.5
50
163
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.5
9.4
322
2187
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.0
9.4
111
549
SPAT1058
SPAT
PEF monitoring instruction
1.5
9.4
368
2572
Z50.1
ICD-10 Finland
Other physical therapy
1.6
9.4
238
1506
N05AC02
ATC
thioridazine; oral
2.1
9.4
102
489
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
2.5
9.4
71
285
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.9
9.4
132
698
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.4
9.4
75
312
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.6
9.4
241
1534
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
3.4
9.4
43
126
G04BD11
ATC
fesoterodine; oral
2.0
9.4
113
565
Y50
ICPC
Male Genital, Medication/prescr/renewal
7.5
9.4
21
28
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
3.1
9.4
50
164
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
3.5
9.4
42
121
S50
ICPC
Skin, Medication/prescr/renewal
3.5
9.4
42
121
25810
ICD-8 Finland
Polyglandular dysfunction and other diseases of endocrine glands, Polyglandular dysfunction
+∞
9.4
9
*
2550C
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERSECRETIO HYPOFYSEOS]
+∞
9.4
9
*
AA4CD
NOMESCO Finland
Very extensive CT of sella turcica
+∞
9.4
9
*
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
2.8
9.4
57
204
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
9.3
83
363
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
9.3
626
4806
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.7
9.3
173
1005
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.5
9.3
332
2278
TGC00
NOMESCO Finland
Bronchial lavation
2.0
9.3
113
569
N05CD02
ATC
nitrazepam; oral
2.4
9.3
74
307
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.6
9.3
63
239
N05AL01
ATC
sulpiride; systemic
2.4
9.3
77
327
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.9
9.3
54
187
R68.2
ICD-10 Finland
Dry mouth, unspecified
3.8
9.3
37
97
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
4.8
9.2
29
60
M01AX01
ATC
nabumetone; oral
1.7
9.2
176
1035
N91.5
ICD-10 Finland
Oligomenorrhoea, unspecified
4.0
9.2
35
88
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.3
9.2
44
134
E30.9
ICD-10 Finland
Disorder of puberty, unspecified
13.6
9.2
15
11
A03
ICPC
Fever
1.3
9.1
900
7285
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
9.1
606
4647
A10AA01
ATC
NA
1.9
9.1
136
737
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.2
9.1
90
415
SPAT1104
SPAT
Monitoring of emergency patient
1.5
9.1
293
1966
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
9.1
598
4582
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
7.7
9.1
20
26
K29.6
ICD-10 Finland
Other gastritis
2.9
9.1
54
190
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
9.1
284
1897
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
9.1
332
2293
H47.1
ICD-10 Finland
Papilloedema, unspecified
3.6
9.1
39
109
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
3.6
9.1
39
109
N07CA01
ATC
betahistine; oral
1.5
9.1
288
1930
H46
ICD-10 Finland
Optic neuritis
2.9
9.0
53
185
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.5
9.0
280
1867
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
3.2
9.0
44
136
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.6
9.0
224
1416
F50.0
ICD-10 Finland
Anorexia nervosa
3.1
9.0
46
147
SPAT1281
SPAT
Other administrative function
1.4
9.0
387
2760
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
3.8
9.0
36
95
WX610
NOMESCO Finland
Patient controlled analgesia
3.3
8.9
42
126
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.0
8.9
48
159
JN4CD
NOMESCO Finland
Very extensive body CT
1.8
8.9
150
849
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.3
8.9
77
332
F60.8
ICD-10 Finland
Other specific personality disorders
3.1
8.9
46
148
SPAT1172
SPAT
Guidance concerning hydration
2.2
8.9
83
373
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.1
8.9
93
439
D12
ICPC
Constipation
1.9
8.9
134
729
F31
ICD-10 Finland
Bipolar affective disorder
2.4
8.9
72
303
WX320
NOMESCO Finland
Spinalanesthesy
1.3
8.9
992
8154
U05
ICPC
Urination problems other
1.7
8.9
188
1136
R30.0
ICD-10 Finland
Dysuria
1.7
8.9
169
991
A27
ICPC
Fear of other disease NOS
1.7
8.9
195
1194
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
2.2
8.9
88
407
H05.2
ICD-10 Finland
Exophthalmic conditions
5.4
8.9
25
46
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
1.7
8.9
164
956
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.0
8.9
109
551
R09
ICPC
Sinus symptom/complaint
1.4
8.9
373
2648
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
8.8
805
6454
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.9
8.8
122
646
N05AE03
ATC
sertindole; oral
4.8
8.8
28
59
E30.09
ICD-10 Finland
Delayed puberty NOS
6.8
8.8
21
31
M89.0
ICD-10 Finland
Algoneurodystrophy
2.9
8.8
51
176
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
2.8
8.8
53
189
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.6
8.8
204
1268
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.0
8.8
48
161
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.0
8.8
111
569
F50.9
ICD-10 Finland
Eating disorder, unspecified
2.5
8.8
67
272
B02AA02
ATC
tranexamic acid; systemic
1.3
8.7
686
5390
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
1.9
8.7
117
612
W19
ICD-10 Finland
Unspecified fall
1.4
8.7
434
3177
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.4
8.7
71
300
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.0
8.7
112
575
Y99
ICPC
Genital disease male other
5.6
8.7
24
43
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
8.7
504
3787
G04BD12
ATC
mirabegron; oral
1.4
8.7
375
2673
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.2
8.7
84
383
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.6
8.7
221
1407
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.2
8.7
81
363
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
2.8
8.7
53
191
L12
ICPC
Hand/finger symptom/complaint
1.3
8.7
682
5359
F51.0
ICD-10 Finland
Nonorganic insomnia
1.3
8.7
631
4908
M01AC01
ATC
piroxicam; systemic, rectal
1.3
8.6
556
4246
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.3
8.6
76
333
DFF00
NOMESCO Finland
Pure tone audiometry
1.4
8.6
377
2695
B35.3
ICD-10 Finland
Tinea pedis
1.7
8.6
174
1040
J01DC02
ATC
cefuroxime; systemic
1.5
8.6
280
1887
G04BD07
ATC
tolterodine; oral
1.7
8.6
186
1134
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.5
8.6
29
65
NHQ40
NOMESCO Finland
Amputation of toe
2.4
8.6
70
295
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
4.1
8.6
32
79
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
8.6
154
886
R03BC03
ATC
nedocromil; inhalant
1.5
8.6
310
2135
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
6.1
8.6
22
36
UJF92
NOMESCO Finland
Capsular endoscopy
2.0
8.6
111
572
N02CC04
ATC
rizatriptan; oral
1.5
8.6
279
1878
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
5.8
8.6
23
40
62600
ICD-8 Finland
Disorders of menstruation, Absent
5.5
8.6
24
44
L60.0
ICD-10 Finland
Ingrowing nail
1.6
8.6
197
1223
K65.0
ICD-10 Finland
Acute peritonitis
2.8
8.5
51
181
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
3.4
8.5
39
115
L29.9
ICD-10 Finland
Pruritus, unspecified
2.0
8.5
107
548
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
2.3
8.5
77
340
L13
ICPC
Hip symptom/complaint
1.3
8.5
613
4760
XX4AW
NOMESCO Finland
NA
3.1
8.5
45
148
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.8
8.5
129
707
R4120
NOMESCO Finland
Occupational therapy
1.5
8.5
300
2059
R06AX27
ATC
desloratadine; oral
1.2
8.5
1499
12928
D01AE16
ATC
amorolfine; topical
1.4
8.5
491
3689
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
2.3
8.4
74
322
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.2
8.4
80
363
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
2.0
8.4
97
478
E83.51
ICD-10 Finland
Hypocalcemia
3.4
8.4
39
116
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.6
8.4
221
1416
9109
FHL
Other measure in this category
7.3
8.4
19
26
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
6.0
8.4
22
37
D07AB08
ATC
desonide; topical
1.4
8.4
493
3711
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
3.2
8.4
41
127
AA4BD
NOMESCO Finland
Extensive CT of sella turcica
90.1
8.4
9
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
2.2
8.4
83
385
AA1AA
NOMESCO Finland
Head X-ray examination
2.8
8.4
50
177
TPH00
NOMESCO Finland
Phlebotomy
4.0
8.4
32
81
WVA30
SPAT
NA
1.9
8.4
124
671
S76
ICPC
Skin infection other
1.6
8.4
216
1378
N05AB04
ATC
prochlorperazine; systemic, rectal
2.0
8.4
95
467
M01AG01
ATC
mefenamic acid; oral
1.9
8.4
122
657
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
3.0
8.4
46
155
S19
ICPC
Skin injury other
1.7
8.4
166
985
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.0
8.4
105
534
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
3.2
8.4
42
133
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.2
8.4
82
378
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
1.4
8.4
340
2401
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.9
8.3
114
602
N05AF05
ATC
zuclopenthixol; systemic
2.6
8.3
57
217
SPAT1284
SPAT
Extensive health certificate
1.8
8.3
135
753
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
8.3
1693
14787
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
4.8
8.3
26
54
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
6.7
8.3
20
30
Z56.5
ICD-10 Finland
Uncongenial work
6.7
8.3
20
30
E89.3
ICD-10 Finland
Postprocedural hypopituitarism
+∞
8.3
8
*
2552A
ICD-9 Finland
Disorders of adrenal glands, Adrenogenital disorders[SYNDROMA ADRENOGENITALE CONGENITUM]
+∞
8.3
8
*
H01AX01
ATC
pegvisomant; parenteral
+∞
8.3
8
*
2554X
ICD-9 Finland
Disorders of adrenal glands, Corticoadrenal insufficiency[HYPOFUNCTIO CORTICOADRENALIS ALIA]
+∞
8.3
8
*
E2300, D352
ICD-10 Finland
NA
+∞
8.3
8
*
D352, E220
ICD-10 Finland
NA
+∞
8.3
8
*
C04AX02
ATC
phenoxybenzamine; oral
+∞
8.3
8
*
Q87.16
ICD-10 Finland
Mulibrey nanism
+∞
8.3
8
*
2538X
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other disorders of the pituitary and other syndromes of diencephalohypophyseal origin[MORBUS HYPOPHYSEOS SEU HYPOTHALAMI ALIA]
+∞
8.3
8
*
E24.1
ICD-10 Finland
Nelson syndrome
+∞
8.3
8
*
E22
ICD-10 Finland
Hyperfunction of pituitary gland
+∞
8.3
8
*
2549
FHL
NA
+∞
8.3
8
*
M35.7
ICD-10 Finland
Hypermobility syndrome
2.3
8.3
71
307
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.3
8.3
516
3917
J20
ICD-10 Finland
Acute bronchitis
1.4
8.3
432
3185
J96.9
ICD-10 Finland
Respiratory failure, unspecified
4.0
8.3
31
77
N01
ICPC
Headache
1.3
8.3
591
4579
F41.3
ICD-10 Finland
Other mixed anxiety disorders
2.3
8.3
74
327
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
3.3
8.3
40
123
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.4
8.3
353
2512
Z50.5
ICD-10 Finland
Speech therapy
2.0
8.3
98
488
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
5.0
8.3
25
50
K11.2
ICD-10 Finland
Sialoadenitis
1.8
8.3
137
772
SFA00
NOMESCO Finland
Small filling
1.3
8.3
602
4679
N18.0
ICD-10 Finland
End-stage renal disease
2.5
8.3
59
233
160
Kela drug reimbursment
exenatide
2.1
8.3
86
405
JN3BG
NOMESCO Finland
MRI examination of abdomen with high intensity magnet
6.2
8.3
21
34
SBA00
NOMESCO Finland
Microbiological examinations
1.9
8.3
123
667
G50.1
ICD-10 Finland
Atypical facial pain
2.2
8.3
81
372
N03AB02
ATC
phenytoin; systemic
2.6
8.3
55
209
SPAT1059
SPAT
Spirometry at the office
1.6
8.3
218
1401
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.3
8.2
507
3846
X57
ICD-10 Finland
Unspecified privation
2.0
8.2
104
531
G04BD08
ATC
solifenacin; oral
1.5
8.2
248
1643
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.7
8.2
54
204
N02CC03
ATC
zolmitriptan; nasal, oral
1.5
8.2
254
1696
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.8
8.2
128
706
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
2.1
8.2
90
435
F05.9
ICD-10 Finland
Delirium, unspecified
2.2
8.1
76
344
F22.0
ICD-10 Finland
Delusional disorder
2.3
8.1
73
324
R81
ICPC
Pneumonia
1.8
8.1
132
740
PAW37
NOMESCO Finland
Biopsy of temporal artery
3.4
8.1
37
109
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
3.5
8.1
36
104
EBA00
NOMESCO Finland
Extraction of tooth
1.2
8.1
1732
15190
J32.3
ICD-10 Finland
Chronic sphenoidal sinusitis
5.6
8.1
22
39
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
3.0
8.1
43
142
B05DA
ATC
Isotonic solutions
3.1
8.1
41
131
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
3.6
8.1
34
94
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.8
8.1
139
794
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.2
8.1
75
338
K92.0
ICD-10 Finland
Haematemesis
2.0
8.1
99
502
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.0
8.1
44
148
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.4
8.1
315
2207
M41.9
ICD-10 Finland
Scoliosis, unspecified
2.4
8.1
64
268
2768A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]
17.2
8.1
12
7
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.5
8.1
228
1490
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
8.0
1702
14914
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.3
8.0
510
3886
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.1
8.0
89
432
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.6
8.0
55
210
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
8.0
921
7588
I84.4
ICD-10 Finland
External hemorrhoids with other complications
2.4
8.0
63
262
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
1.8
8.0
136
772
C08DB01
ATC
diltiazem; oral
1.7
8.0
173
1056
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
2.3
8.0
68
292
F32.8
ICD-10 Finland
Other depressive episodes
2.2
8.0
75
341
ACC51
NOMESCO Finland
Release of median nerve
1.4
8.0
318
2236
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.0
8.0
91
447
N06AX17
ATC
milnacipran; oral
2.4
8.0
63
263
N91.0
ICD-10 Finland
Primary amenorrhoea
5.8
8.0
21
36
K08.80
ICD-10 Finland
Toothache NOS
1.4
8.0
369
2671
X78
ICD-10 Finland
Intentional self-harm by sharp object
3.0
8.0
43
144
F41.00
ICD-10 Finland
Moderate panic disorder
2.0
7.9
93
461
Z08
ICPC
Social welfare problem
2.4
7.9
62
256
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
7.2
7.9
18
25
J01MA06
ATC
norfloxacin; oral
1.3
7.9
583
4542
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.3
7.9
73
326
D06
ICPC
Abdominal pain localized other
1.4
7.9
380
2766
F32
ICD-10 Finland
Depressive episode
1.5
7.9
256
1726
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.0
7.8
90
443
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
2.6
7.8
54
207
R21
ICPC
Throat symptom/complaint
1.2
7.8
1105
9309
I50.0
ICD-10 Finland
Congestive heart failure
1.6
7.8
218
1421
RS142
NOMESCO Finland
NA
4.5
7.8
26
58
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.2
7.8
73
330
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
3.9
7.8
30
77
Z01.7
ICD-10 Finland
Laboratory examination
1.3
7.8
504
3853
188
Kela drug reimbursment
Psychosis requiring demanding treatment
2.4
7.8
62
260
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
4.3
7.8
27
63
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
10.8
7.8
14
13
D01AC02
ATC
miconazole; topical
1.4
7.8
329
2340
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.6
7.8
174
1074
A10BB12
ATC
glimepiride; oral
1.5
7.8
232
1534
B01AB04
ATC
dalteparin; parenteral
1.6
7.7
190
1199
H93.1
ICD-10 Finland
Tinnitus
1.5
7.7
272
1863
WW500
NOMESCO Finland
Blood transfusion
1.6
7.7
172
1059
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
2.0
7.7
90
449
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.0
7.7
42
142
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
1.8
7.7
122
679
WVA20
SPAT
NA
2.6
7.7
53
204
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
2.3
7.7
69
306
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.4
7.7
358
2592
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.0
7.7
91
455
5BA08
NOMESCO Finland
NA
3.4
7.7
35
104
C09CA03
ATC
valsartan; oral
1.4
7.7
325
2315
J20.8
ICD-10 Finland
Acute bronchitis due to other specified organisms
4.6
7.7
25
55
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
4.6
7.7
25
55
120
Kela drug reimbursment
Hypogammaglobulinaemia
5.5
7.6
21
38
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
7.6
179
1115
SPAT1125
SPAT
Stoma care and guidance
2.4
7.6
60
249
N92.2
ICD-10 Finland
Excessive menstruation at puberty
3.9
7.6
29
74
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
7.6
691
5536
I45.9
ICD-10 Finland
Conduction disorder, unspecified
2.9
7.6
42
143
J01FA01
ATC
erythromycin; systemic
1.3
7.6
703
5642
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
7.6
31
84
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
2.2
7.6
74
341
2761A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hyposmolality and/or hyponatraemia
18.3
7.6
11
6
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.1
7.6
82
397
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
2.5
7.6
56
224
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
1.7
7.6
134
772
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
2.1
7.6
79
376
KH1AD
NOMESCO Finland
CT of urinary organs
1.8
7.6
132
757
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
4.2
7.6
27
65
B05DB
ATC
Hypertonic solutions
3.4
7.5
34
100
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
3.4
7.5
34
100
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.6
7.5
188
1194
TQW99
NOMESCO Finland
Other minor procedure on skin
1.6
7.5
199
1282
-56
ICPC
Dressing/pressure/compress/tamponade
2.1
7.5
76
356
R94.7
ICD-10 Finland
Abnormal results of other endocrine function studies
8.8
7.5
15
17
F45.8
ICD-10 Finland
Other somatoform disorders
1.4
7.5
341
2458
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
3.9
7.5
29
75
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
1.7
7.5
132
761
IFB02
NOMESCO Finland
Transcranial magnetic stimulation (TMS)
5.7
7.5
20
35
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
2.4
7.5
60
253
A08
ICPC
Swelling
1.7
7.5
161
982
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
2.8
7.5
45
162
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
2.8
7.5
45
162
H04AA01
ATC
glucagon; nasal, parenteral
1.7
7.5
140
820
Z2221
NOMESCO Finland
Medical doctor
1.2
7.4
1421
12323
R03BC01
ATC
cromoglicic acid; inhalant
2.1
7.4
81
394
-1
SPAT
NA
1.6
7.4
190
1214
N05BB01
ATC
hydroxyzine; systemic
1.4
7.4
284
1985
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
1.8
7.4
120
674
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
3.3
7.4
35
107
R04.2
ICD-10 Finland
Haemoptysis
1.8
7.4
125
711
Z73.9
ICD-10 Finland
Problem related to life-management difficulty, unspecified
2.6
7.4
49
187
G44.8
ICD-10 Finland
Other specified headache syndromes
2.3
7.4
62
268
WX204
NOMESCO Finland
Axillary plexus blockaced
1.7
7.4
134
780
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
5.9
7.4
19
32
D82
ICPC
Teeth/gum disease
1.2
7.3
1868
16602
M01AH05
ATC
etoricoxib; oral
1.2
7.3
3072
28355
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.7
7.3
47
173
RJ421
NOMESCO Finland
NA
4.0
7.3
27
67
RJ411
NOMESCO Finland
NA
3.5
7.3
32
92
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
2.2
7.3
67
301
H05BX01
ATC
cinacalcet; oral
3.6
7.3
31
87
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.3
7.3
497
3826
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
4.3
7.3
25
58
X58
ICD-10 Finland
Exposure to other specified factors
1.3
7.3
686
5519
N18
ICPC
Paralysis/weakness
2.1
7.3
75
356
8010/3-C74.9
ICD-O-3
Carcinoma, NOS, of adrenal gland, NOS
+∞
7.3
7
*
1940B
ICD-9 Finland
Malignant neoplasm of other endocrine glands and related structures, Adrenal gland[NEUROBLASTOMA SUPRARENALIS]
+∞
7.3
7
*
E31.01
ICD-10 Finland
Schmidt's syndrome
+∞
7.3
7
*
9350/1-C75.1
ICD-O-3
Craniopharyngioma, NOS, of pituitary gland
+∞
7.3
7
*
8370/3-C74.9
ICD-O-3
Adrenal cortical carcinoma of adrenal gland, NOS
+∞
7.3
7
*
25312
ICD-8 Finland
Diseases of pituitary gland, Nanismus hypophysarius
+∞
7.3
7
*
E22.8
ICD-10 Finland
Other hyperfunction of pituitary gland
+∞
7.3
7
*
2539X
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Unspecified
+∞
7.3
7
*
2591A
ICD-9 Finland
Other endocrine disorders, Precocious sexual development and puberty, not elsewhere classified
+∞
7.3
7
*
AA4WT
NOMESCO Finland
Selective blood sample from sinus petrosus inferior
10.8
7.3
13
12
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2.8
7.3
44
159
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
2.5
7.3
52
207
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
2.5
7.3
52
207
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.0
7.3
84
418
MAX99
NOMESCO Finland
Assistance to normal delivery
0.7
7.3
194
2827
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.6
7.3
164
1016
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
1.9
7.3
99
525
C01DA14
ATC
isosorbide mononitrate; oral
1.3
7.3
482
3702
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
3.2
7.2
35
109
S51.8
ICD-10 Finland
Open wound of other parts of forearm
2.4
7.2
55
226
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.0
7.2
92
473
A10AA02
ATC
NA
1.7
7.2
147
885
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.1
7.2
72
337
WX308
NOMESCO Finland
Sacral anesthesy
3.5
7.2
31
88
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
1.6
7.2
157
962
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
1.9
7.2
94
487
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.8
7.2
127
730
196
Kela drug reimbursment
Paricalcitol and cinacalcet
3.7
7.2
29
78
BBA20
NOMESCO Finland
Exploration of parathyroid gland
5.1
7.2
21
41
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.0
7.2
83
411
B34.9
ICD-10 Finland
Viral infection, unspecified
1.6
7.2
155
948
R05
ICPC
Cough
1.2
7.2
1093
9275
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
1.7
7.2
127
734
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.3
7.2
576
4542
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.7
7.1
46
171
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.8
7.1
112
624
XA402
NOMESCO Finland
ENMG
1.8
7.1
117
658
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
20.0
7.1
10
5
NGQ20
NOMESCO Finland
Amputation of lower leg
3.8
7.1
28
74
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
3.7
7.1
29
79
1410
FHL
Laparoscopy
1.8
7.1
113
628
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
2.2
7.1
69
320
D07XC01
ATC
betamethasone, combinations; topical
1.3
7.1
506
3923
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.0
7.1
80
393
AWE00
NOMESCO Finland
Reoperation for deep heamorrhage in surgery of the nervous system
6.5
7.1
17
26
2152
FHL
Extraction, big brain
6.5
7.1
17
26
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
2.5
7.1
50
197
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.6
7.1
183
1173
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
7.1
807
6643
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.6
7.1
186
1197
E21.2
ICD-10 Finland
Other hyperparathyroidism
4.2
7.1
25
60
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.7
7.1
135
799
K59.9
ICD-10 Finland
Functional intestinal disorder, unspecified
2.2
7.1
66
301
SPAT1094
SPAT
Continuous Positive Airway Pressure
2.4
7.1
54
223
3028
Kela drug reimbursment
Mepolizumab
12.0
7.1
12
10
R06.4
ICD-10 Finland
Hyperventilation
2.0
7.1
85
431
XX1VW
NOMESCO Finland
Written report from radiologist
3.0
7.1
38
128
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.5
7.1
246
1685
H01
ICPC
Ear pain/earache
1.3
7.0
550
4321
ECB00
NOMESCO Finland
Suture of gingiva
1.7
7.0
150
915
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
1.7
7.0
145
877
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.3
7.0
587
4653
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.0
7.0
84
423
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.6
7.0
47
181
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
2.6
7.0
47
181
N05BA02
ATC
chlordiazepoxide; systemic
1.8
7.0
103
561
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
4.7
7.0
22
47
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.6
7.0
49
192
M54.6
ICD-10 Finland
Pain in thoracic spine
1.4
7.0
299
2136
H50.1
ICD-10 Finland
Divergent concomitant strabismus
2.7
7.0
43
158
L50.9
ICD-10 Finland
Urticaria, unspecified
1.6
7.0
169
1066
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
2.4
7.0
53
218
I95
ICD-10 Finland
Hypotension
4.1
7.0
25
61
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
2.4
7.0
56
237
F84.5
ICD-10 Finland
Asperger syndrome
2.9
7.0
40
138
Z49.2
ICD-10 Finland
Other dialysis
2.9
7.0
40
138
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.6
6.9
175
1113
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
3.6
6.9
29
81
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
3.8
6.9
27
71
E87.2
ICD-10 Finland
Acidosis
3.7
6.9
28
76
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.4
6.9
382
2850
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.4
6.9
266
1860
XG405
NOMESCO Finland
Education on PEF monitoring
2.2
6.9
64
289
K80.8
ICD-10 Finland
Other cholelithiasis
2.1
6.9
70
331
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.4
6.9
355
2617
A10BX07
ATC
[U] liraglutide; parenteral
2.4
6.9
55
230
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.7
6.9
140
842
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.4
6.9
328
2388
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
2.9
6.9
40
140
H02AB02
ATC
dexamethasone; systemic
1.3
6.9
418
3166
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.7
6.9
145
882
SPAT1197
SPAT
Extensive health check-up of expecting family
0.7
6.9
326
4326
130
Kela drug reimbursment
Malignant tumour
1.4
6.9
292
2082
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.1
6.9
69
324
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.7
6.9
143
865
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
4.6
6.9
22
48
TQW40
NOMESCO Finland
Remowal of suture of skin
1.4
6.9
299
2144
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.6
6.9
176
1128
S01
ICPC
Pain/tenderness of skin
1.6
6.9
179
1151
A10BX02
ATC
repaglinide; oral
2.6
6.9
48
187
D21
ICPC
Swallowing problem
2.4
6.8
53
221
XKD03
NOMESCO Finland
Urethral pressure profilometry
1.9
6.8
91
476
D09
ICPC
Nausea
1.5
6.8
229
1559
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
3.9
6.8
26
67
R51.81
ICD-10 Finland
Facial pain NOS
1.9
6.8
99
534
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
1.9
6.8
101
549
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.6
6.8
46
178
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
2.1
6.8
74
360
6BA02
NOMESCO Finland
NA
3.8
6.8
27
72
HMAK
NOMESCO Finland
NA
1.3
6.8
577
4578
J30.3
ICD-10 Finland
Other allergic rhinitis
1.6
6.8
166
1049
C07AB03
ATC
atenolol; systemic
1.5
6.8
197
1295
WF099
NOMESCO Finland
Other radiotherapy
3.3
6.8
32
98
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
3.0
6.8
36
120
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.5
6.8
249
1725
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.1
6.8
69
326
Q32.21
ICD-10 Finland
Secondary congenital bronchomalacia
8.2
6.8
14
17
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
1.9
6.8
91
479
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
2.1
6.8
71
339
R49.01
ICD-10 Finland
Functional dysphonia
1.7
6.8
125
729
I49.5
ICD-10 Finland
Sick sinus syndrome
1.7
6.8
120
694
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
2.5
6.8
48
189
G40
ICD-10 Finland
Epilepsy
2.6
6.8
45
172
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.7
6.8
132
783
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.8
114
647
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
10.9
6.8
12
11
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
2.3
6.8
60
264
C02CA01
ATC
prazosin; oral
2.3
6.8
60
264
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.8
6.8
107
598
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
5.0
6.8
20
40
N07BB01
ATC
disulfiram; oral
1.5
6.8
198
1308
M03AX01
ATC
botulinum toxin; parenteral
2.3
6.7
60
266
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.9
6.7
93
497
Z72.8
ICD-10 Finland
Other problems related to lifestyle
3.1
6.7
34
110
H25.8
ICD-10 Finland
Other senile cataract
1.4
6.7
331
2421
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
3.7
6.7
27
73
L08
ICPC
Shoulder symptom/complaint
1.2
6.7
816
6763
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.4
6.7
255
1781
183
Kela drug reimbursment
Lamotrigin and topiramate
2.3
6.7
58
256
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
4.3
6.7
23
54
J01
ICD-10 Finland
Acute sinusitis
1.5
6.7
221
1502
E28.1
ICD-10 Finland
Ovarian dysfunction: Androgen excess
22.5
6.7
9
*
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
2.7
6.7
41
151
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.3
6.7
507
3972
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
2.5
6.6
48
193
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.4
6.6
315
2292
ZZA00
NOMESCO Finland
Split skin graft
1.8
6.6
111
630
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
3.9
6.6
25
64
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
1.6
6.6
175
1128
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
3.7
6.6
27
74
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
3.7
6.6
27
74
M01AB01
ATC
indometacin; systemic, rectal
1.4
6.6
275
1955
B07.9
ICD-10 Finland
Verruca simplex
1.6
6.6
162
1023
M01AB05
ATC
diclofenac; systemic, rectal
1.1
6.6
3554
33280
L29.8
ICD-10 Finland
Other pruritus
2.5
6.6
50
204
N05BA05
ATC
potassium clorazepate; oral
2.7
6.6
43
162
A07EC01
ATC
sulfasalazine; oral, rectal
1.4
6.6
353
2622
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.6
6.6
142
869
T27
ICPC
Fear endocrine/metabol disease other
2.3
6.6
54
232
KMAK
NOMESCO Finland
NA
1.1
6.6
2818
25984
R39.1
ICD-10 Finland
Other difficulties with micturition
1.8
6.6
114
654
L11
ICPC
Wrist symptom/complaint
1.4
6.6
366
2735
R68.81
ICD-10 Finland
A constant or recurrent sensitivity to experience symptoms and signs in relation to common factors in the environment, not elsewhere classified.
12.2
6.6
11
9
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
2.3
6.6
56
244
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.6
1709
15195
J01CE02
ATC
phenoxymethylpenicillin; oral
1.1
6.5
3985
37623
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
2.2
6.5
64
297
I15.8
ICD-10 Finland
Other secondary hypertension
3.9
6.5
25
65
H02.4
ICD-10 Finland
Ptosis of eyelid
1.8
6.5
103
576
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
2.9
6.5
36
124
E28.8
ICD-10 Finland
Other ovarian dysfunction
10.0
6.5
12
12
C02DE02
ATC
NA
2.4
6.5
51
215
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
6.8
6.5
15
22
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.2
6.5
61
278
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.7
6.5
115
665
K06.18
ICD-10 Finland
Another gingival hyperplasia
3.4
6.5
29
86
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
2.9
6.5
35
119
ED1AA
NOMESCO Finland
Mandipular X-ray examination
3.1
6.5
33
108
G41.9
ICD-10 Finland
Status epilepticus, unspecified
3.1
6.5
33
108
P28
ICPC
Limited function/disability (P)
2.5
6.4
46
183
M70.7
ICD-10 Finland
Other bursitis of hip
1.8
6.4
94
511
N06AA22
ATC
NA
2.9
6.4
37
128
D01AC03
ATC
econazole; topical
1.4
6.4
247
1730
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
1.6
6.4
152
953
M01AH03
ATC
valdecoxib; oral
1.4
6.4
261
1847
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
1.8
6.4
104
587
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
69.8
6.4
7
*
C75.1
ICD-10 Finland
Malignant neoplasm: Pituitary gland
69.8
6.4
7
*
L04AA13
ATC
leflunomide; oral
1.7
6.4
111
639
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.1
6.4
64
302
L99
ICPC
Musculoskeletal disease other
2.0
6.4
77
389
RS230
NOMESCO Finland
NA
2.9
6.4
35
120
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.2
6.4
58
261
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.3
6.4
466
3626
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
4.2
6.4
22
52
E66.1
ICD-10 Finland
Drug-induced obesity
4.2
6.4
22
52
U29
ICPC
Urinary symptom/complaint other
1.8
6.4
109
625
B80
ICPC
Iron deficiency anaemia
1.9
6.4
90
485
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.4
6.4
245
1717
H35.20
ICD-10 Finland
Proliferative vitreoretinopathy
14.3
6.4
10
7
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
3.0
6.4
33
109
H52.1
ICD-10 Finland
Myopia
1.6
6.4
153
962
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
4.7
6.4
20
43
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
2.1
6.4
70
342
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
4.0
6.4
23
57
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
2.5
6.4
45
177
IGY02
NOMESCO Finland
Psychiatric monitoring contact
1.6
6.4
138
846
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
6.4
612
4941
S88
ICPC
Dermatitis contact/allergic
1.9
6.4
87
461
A02BA03
ATC
famotidine; systemic
1.6
6.3
143
888
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
2.6
6.3
43
168
CE2W4
NOMESCO Finland
Eye movement mapping
6.5
6.3
15
23
R1260
NOMESCO Finland
Evaluation of communicative skills
2.0
6.3
74
370
XX9XW
NOMESCO Finland
NA
2.4
6.3
49
205
TKC22
NOMESCO Finland
Catheterisation instruction
1.9
6.3
83
436
TAB20
NOMESCO Finland
Epidural puncture
2.7
6.3
41
154
GD1UN
NOMESCO Finland
Lung circulation SPECT
3.1
6.3
31
99
K11.70
ICD-10 Finland
Hypoptyalism
3.1
6.3
31
99
WX704
NOMESCO Finland
Intubation
1.4
6.3
303
2210
H26.02
ICD-10 Finland
Presenil cataract
1.7
6.3
110
636
M50.8
ICD-10 Finland
Other cervical disc disorders
3.4
6.3
28
83
1XC02
NOMESCO Finland
NA
2.9
6.3
34
116
297
Kela drug reimbursment
NA
11.0
6.3
11
10
E34.45
ICD-10 Finland
Abnormal growth increase
5.9
6.3
16
27
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.7
6.3
108
621
K20
ICD-10 Finland
Oesophagitis
2.1
6.3
65
311
107
Kela drug reimbursment
Pernicious anaemia
2.0
6.3
70
346
D02AX
ATC
Other emollients and protectives
1.5
6.3
177
1159
T50
ICPC
Metabolic, Medication/prescr/renewal
4.6
6.3
20
44
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
3.6
6.3
26
73
E220, D352
ICD-10 Finland
NA
+∞
6.2
6
*
25301
ICD-8 Finland
Diseases of pituitary gland, Gigantismus hypophysarius et hyperpituitarismus alius
+∞
6.2
6
*
E26
ICD-10 Finland
Hyperaldosteronism
+∞
6.2
6
*
2541
FHL
Transformal hypophysketomy
+∞
6.2
6
*
C74
ICD-10 Finland
Malignant neoplasm of adrenal gland
+∞
6.2
6
*
B06AC02
ATC
icatibant; parenteral
+∞
6.2
6
*
E31.0
ICD-10 Finland
Autoimmune polyglandular failure
+∞
6.2
6
*
2536X
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other disorders of neurohypophysis
+∞
6.2
6
*
Q96.9
ICD-10 Finland
Turner syndrome, unspecified
+∞
6.2
6
*
8510/3-C73.9
ICD-O-3
Medullary carcinoma, NOS, of thyroid gland
+∞
6.2
6
*
D72.1
ICD-10 Finland
Eosinophilia
3.8
6.2
24
63
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
1.6
6.2
158
1009
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
1.9
6.2
78
402
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.8
6.2
98
547
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
1.9
6.2
80
416
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
6.2
123
736
TEG00
NOMESCO Finland
Punction of mandibular joint
7.0
6.2
14
20
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.3
6.2
417
3211
J37.0
ICD-10 Finland
Chronic laryngitis
1.7
6.2
128
775
A06AC07
ATC
triticum (wheat fibre); oral
4.1
6.2
22
54
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
3.5
6.2
26
74
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
3.5
6.2
26
74
ELA30
NOMESCO Finland
Biopsy of salivary gland
5.0
6.2
18
36
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
3.2
6.1
29
90
30188
ICD-8 Finland
Personality disorders, Alia definita
3.8
6.1
24
64
G62.8
ICD-10 Finland
Other specified polyneuropathies
2.9
6.1
34
118
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
2.4
6.1
47
193
N76
ICPC
Neoplasm nervous system unspecified
6.3
6.1
15
24
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
6.3
6.1
15
24
B01AF02
ATC
apixaban; oral
1.4
6.1
309
2273
A11CC02
ATC
dihydrotachysterol; oral
4.4
6.1
20
45
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.6
6.1
157
1008
K04.0
ICD-10 Finland
Pulpitis
1.3
6.1
475
3730
S22.3
ICD-10 Finland
Fracture of rib
1.4
6.1
254
1805
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
5.7
6.1
16
28
A10BG03
ATC
pioglitazone; oral
1.8
6.1
93
512
R41.3
ICD-10 Finland
Other amnesia
1.8
6.1
97
543
J01DC04
ATC
cefaclor; oral
2.0
6.1
75
384
J96.1
ICD-10 Finland
Chronic respiratory failure
2.0
6.1
71
357
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
2.3
6.1
50
214
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
1.6
6.1
155
993
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
2.9
6.1
33
113
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.6
6.1
132
810
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
2.7
6.1
37
136
P80
ICPC
Personality disorder
3.0
6.1
31
102
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.0
6.1
68
336
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
12.5
6.1
10
8
Q87.14
ICD-10 Finland
Noonan's syndrome
12.5
6.1
10
8
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
12.5
6.1
10
8
J01CF02
ATC
cloxacillin; systemic
1.8
6.1
93
516
F48.0
ICD-10 Finland
Neurasthenia
3.8
6.1
23
60
R19.4
ICD-10 Finland
Change in bowel habit
1.8
6.0
91
502
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
3.7
6.0
24
65
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.5
6.0
191
1284
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.1
6.0
63
302
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.5
6.0
182
1212
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.0
6.0
66
325
ZZC00
NOMESCO Finland
Graft of fascia
6.7
6.0
14
21
C03DB01
ATC
amiloride; oral
6.7
6.0
14
21
NFK20
NOMESCO Finland
Epiphysiodesis of femur
6.7
6.0
14
21
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
6.7
6.0
14
21
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
3.3
6.0
27
81

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
1907
427
59.52
307.65
3.1
2.0
nmol/l
19.3
20.8
2.00
1850
410
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
652
152
46.85
307.65
1.8
1.2
mu/l
1120.9
363.6
3.85
628
144
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
963
1247
8.71
307.65
3.1
1.8
pmol/l
174.6
201.7
7.48
931
1172
(3021387) Prolactin [Units/volume] in Serum or Plasma
2332
2482
13.18
307.65
3.7
1.3
mu/l
434.2
292.0
11.28
2243
2223
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
658
157
45.82
307.65
1.8
1.2
%
74.1
71.6
1.34
634
149
(3008295) Osmolality of Serum or Plasma
488
576
8.99
307.65
2.3
1.3
mosm/kgh2o
282.9
281.6
0.43
422
453
(3035637) Corticotropin [Mass/volume] in Plasma
1326
717
22.24
307.65
2.3
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
2058
4433
6.02
307.65
5.3
2.0
nmol/l
11.2
12.7
11.83
1904
3903
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4540
28066
2.56
307.65
10.1
6.9
mmol/l
1.2
1.2
0.37
3740
23916
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
843
143
66.25
307.65
3.4
2.4
ug/l
1.1
1.6
1.94
791
136
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
688
1061
7.03
307.65
1.8
1.4
nmol/l
0.3
0.4
3.79
504
839
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
847
789
11.97
307.65
3.1
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1331
3830
4.01
307.65
3.3
3.3
pmol/l
4.4
4.5
6.90
1217
3416
(3009214) Lutropin [Units/volume] in Serum or Plasma
1858
2094
11.46
307.65
2.1
1.4
u/l
7.6
9.4
4.98
1482
1634
(3036481) Cortisol [Moles/volume] in Serum or Plasma
3870
5416
13.70
307.65
4.7
2.0
nmol/l
322.8
373.1
25.57
3666
4984
(43055514) Macroprolactin [Presence] in Serum or Plasma
524
117
48.04
307.65
1.7
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
1352
3568
4.40
307.65
1.9
1.4
iu/l
17.3
26.2
20.36
1105
2987
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
1139
1813
7.22
307.65
3.0
1.7
nmol/l
34.6
40.4
8.24
1096
1767
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
325
263
12.86
307.65
2.5
1.5
nmol/l
4.5
5.4
0.17
277
201
(3011985) Renin [Units/volume] in Plasma
636
716
9.61
307.65
3.4
1.3
mu/l
78.3
60.1
1.09
594
631
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
398
71
59.10
307.65
2.0
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4174
25527
2.43
301.12
9.5
6.3
mmol/l
1.2
1.2
0.76
3916
23318
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
6344
47437
3.19
297.82
6.9
3.9
pmol/l
14.8
14.6
6.42
6051
43552
(3030313) Adrenal Ab [Titer] in Serum
177
53
34.16
278.78
1.2
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
504
891
5.99
273.23
2.0
1.4
mmol/l
76.0
65.2
4.39
439
721
(3018418) pH of Serum or Plasma
2970
16278
2.36
265.99
5.8
4.0
ph
7.4
7.4
0.36
828
3094
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
411
613
7.03
263.16
1.7
1.3
nmol/l
29.6
36.4
—
5
8
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
334
401
8.67
257.94
1.9
1.3
umol/l
4.2
5.0
2.23
302
366
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
509
1029
5.23
238.00
1.9
1.3
u/l
17.1
24.7
6.29
431
858
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3838
24565
2.15
223.41
3.3
2.3
nmol/l
76.7
75.5
2.06
3567
22464
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
393
703
5.84
209.78
1.4
1.3
pmol/l
309.4
296.3
0.24
306
546
(3013826) Glucose [Moles/volume] in Serum or Plasma
4811
34227
2.13
204.34
7.2
4.7
mmol/l
6.6
6.6
0.58
4579
31782
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1638
7636
2.46
202.68
7.4
6.8
mmol/l
1.1
1.1
1.12
1556
7154
(3024561) Albumin [Mass/volume] in Serum or Plasma
3724
24196
2.07
200.93
6.4
5.0
g/l
35.4
36.0
9.72
3513
22556
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
400
757
5.52
200.90
2.2
1.2
nmol/l
1.1
0.6
0.66
389
730
(3026782) Osmolality of Urine
2153
11348
2.26
200.35
3.8
2.7
mosm/kgh2o
517.6
553.0
10.32
1908
9688
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
396
771
5.36
192.67
2.2
1.2
nmol/l
0.4
0.3
0.16
45
38
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
370
689
5.59
189.01
2.2
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5740
44775
2.20
177.51
10.0
7.2
u/l
80.9
79.1
1.37
5508
42260
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6681
55989
2.77
169.55
7.4
4.6
mu/l
1.8
2.1
3.40
6316
51944
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1061
4408
2.64
164.56
5.6
3.8
mmol/l
1.2
1.2
2.51
990
3849
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1743
9122
2.19
159.88
4.8
4.1
mmol/l
0.8
0.8
0.23
1641
8548
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4133
29569
1.88
151.57
7.5
6.1
umol/l
10.5
11.4
3.45
3919
27961
(3023368) Bacteria identified in Blood by Culture
2402
14498
1.96
147.50
5.9
4.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1499
7623
2.21
146.27
3.1
2.6
%
22.7
23.1
0.40
1289
6596
(3006315) Basophils [#/volume] in Blood
4250
30950
1.86
144.43
8.1
6.3
e9/l
0.0
0.0
0.12
3815
26805
(3001604) Monocytes [#/volume] in Blood
4238
30844
1.86
144.20
8.1
6.3
e9/l
0.6
0.6
8.25
3808
26726
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1577
8233
2.16
143.73
2.9
2.5
g/l
2.4
2.4
0.14
1468
7653
(3013115) Eosinophils [#/volume] in Blood
4353
32007
1.86
142.67
8.5
6.6
e9/l
0.2
0.2
0.35
3942
28215
(3015377) Calcium [Moles/volume] in Serum or Plasma
2894
18759
1.88
141.91
3.9
3.3
mmol/l
2.3
2.4
4.52
2587
16548
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2636
16605
1.90
141.04
2.8
2.2
u/l
240.3
226.2
0.09
2502
15628
(42870588) Differential panel, method unspecified - Blood
3144
20955
1.86
140.89
8.0
6.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2390
14583
1.94
140.82
2.7
2.3
mg/l
3.0
2.9
1.99
2120
12554
(3019198) Lymphocytes [#/volume] in Blood
4320
31840
1.84
138.85
8.2
6.3
e9/l
2.0
2.0
0.06
3928
28160
(3022948) Iron [Moles/volume] in Serum or Plasma
1655
8974
2.08
135.62
3.0
2.5
umol/l
13.0
13.5
1.89
1551
8382
(3022096) Basophils/100 leukocytes in Blood
3918
28177
1.82
134.98
8.5
6.5
%
0.6
0.7
4.79
3740
26410
(3013650) Neutrophils [#/volume] in Blood by Automated count
4658
35351
1.84
133.74
11.8
9.3
e9/l
4.3
4.0
13.06
4232
30819
(3019069) Monocytes/100 leukocytes in Blood
4021
29212
1.81
133.25
8.7
6.7
%
8.5
8.5
0.16
3848
27498
(3006504) Eosinophils/100 leukocytes in Blood
4003
29055
1.81
132.93
8.4
6.4
%
2.8
2.9
2.38
3814
27194
(3027801) Oxygen [Partial pressure] in Arterial blood
1219
5937
2.26
130.93
8.1
7.7
kpa
13.0
12.7
0.77
1158
5667
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1219
5938
2.26
130.88
8.1
7.7
kpa
5.1
5.1
0.55
1164
5669
(37021550) Renin [Units/volume] in Plasma --upright
128
104
12.50
129.98
2.1
1.2
mu/l
94.5
51.9
1.62
115
81
(3003396) Base excess in Arterial blood by calculation
1213
5918
2.25
129.64
8.1
7.7
mmol/l
0.9
1.0
0.21
960
4601
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3842
27735
1.79
128.11
3.7
2.9
ug/l
120.3
110.0
1.90
3613
25964
(3032080) INR in Blood by Coagulation assay
3162
21581
1.80
127.29
10.2
8.1
inr
1.2
1.2
1.31
1160
6362
(3002030) Lymphocytes/100 leukocytes in Blood
4091
30195
1.78
125.32
8.5
6.5
%
28.4
29.1
3.07
3904
28286
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2733
17926
1.82
124.99
3.3
2.6
u/l
56.7
57.8
0.22
2537
16592
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
222
378
6.02
124.32
1.5
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
5502
44501
1.89
122.79
5.5
4.0
mm/h
12.0
11.0
6.03
5203
41517
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
947
4269
2.39
121.22
9.4
8.8
mmol/l
24.7
24.8
0.64
940
4249
(3018010) Neutrophils/100 leukocytes in Blood
4020
29752
1.76
119.74
8.1
6.3
%
56.9
56.3
2.68
3848
27975
(3005719) IgG [Mass/volume] in Serum or Plasma
1036
4882
2.30
119.63
3.2
2.8
g/l
9.9
10.4
2.82
910
4512
(3016038) Potassium [Moles/volume] in Urine
215
370
5.95
119.07
1.7
1.4
mmol/l
34.4
36.8
0.55
192
332
(3021589) Normoblasts [#/volume] in Blood
3782
27552
1.75
118.73
14.8
9.3
e9/l
0.0
0.0
0.47
3269
22416
(3017181) Myelocytes/100 leukocytes in Blood
1034
4887
2.29
118.50
5.1
4.3
%
0.9
0.9
0.05
347
1304
(3021440) Promyelocytes/100 leukocytes in Blood
985
4655
2.28
112.55
5.2
4.3
%
0.1
0.1
1.27
329
1201
(3002179) Metamyelocytes/100 leukocytes in Blood
954
4483
2.29
110.36
4.8
4.1
%
0.5
0.6
0.35
271
940
(3025159) Blasts/100 leukocytes in Blood
942
4418
2.29
109.42
5.3
4.4
%
0.0
0.2
1.11
292
1005
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2180
13879
1.80
106.35
3.4
3.1
ng/l
1357.0
1280.4
0.20
1855
11722
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3130
22103
1.71
105.82
2.1
1.9
pmol/l
97.1
96.5
0.27
1701
11653
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1543
8838
1.94
105.00
2.3
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2924
20301
1.72
104.95
4.7
3.3
ng/l
33.1
73.6
0.94
2054
12477
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
258
592
4.47
102.78
3.8
3.0
nmol/l
6.1
14.7
0.44
247
572
(3014576) Chloride [Moles/volume] in Serum or Plasma
1256
6748
2.03
102.51
8.3
7.3
mmol/l
104.1
104.6
2.16
1231
6606
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
886
4181
2.27
100.98
4.6
4.4
ng/l
87.2
85.8
0.13
764
3668
(1616796) Gas panel - Central venous blood
393
1246
3.27
98.28
5.2
3.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
6196
53367
1.92
97.56
6.9
5.2
mmol/mol
39.8
39.1
7.04
5883
49897
(3016502) Oxygen saturation in Arterial blood
1033
5269
2.11
96.58
8.8
8.2
%
95.8
95.9
0.25
996
5073
(3024980) IgG subclass 4 [Mass/volume] in Serum
352
1054
3.45
96.42
1.6
1.7
g/l
0.7
0.8
1.00
203
828
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
111
114
9.86
96.28
3.2
1.6
nmol/l
5.1
4.2
0.70
106
107
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
145
213
6.92
93.72
1.6
1.5
pmol/l
13.7
15.0
1.45
130
180
(3010421) pH of Blood
429
1484
3.00
92.42
5.6
4.3
ph
7.4
7.4
0.28
381
1249
(3012501) Base excess in Blood by calculation
388
1268
3.17
92.20
5.7
4.4
mmol/l
2.6
2.4
0.38
289
848
(3013290) Carbon dioxide [Partial pressure] in Blood
388
1269
3.17
92.08
5.7
4.4
kpa
5.0
5.0
0.34
381
1250
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
831
3967
2.23
91.65
2.1
1.7
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
388
1276
3.15
91.22
5.7
4.3
kpa
8.6
8.7
0.69
381
1256
(40767503) Oxygen content in Capillary blood by calculation
366
1163
3.26
91.12
3.4
2.5
%
16.4
16.7
0.48
190
590
(3019550) Sodium [Moles/volume] in Serum or Plasma
6855
61695
2.29
88.71
26.6
14.2
mmol/l
139.4
139.6
10.97
6763
60134
(3001556) Androgen free Index in Serum or Plasma
87
71
12.38
88.03
2.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
2111
13941
1.71
87.33
6.5
4.5
—
—
—
0
0
(4062490)
260
680
3.92
86.95
1.6
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1560
9477
1.81
86.18
2.0
1.7
nmol/l
1270.2
1164.8
4.08
1224
7243
(3023103) Potassium [Moles/volume] in Serum or Plasma
6861
61899
2.27
86.07
26.6
14.3
mmol/l
3.9
4.0
3.71
6758
60197
(3002582) Erythrocytes [#/volume] in Urine
2540
17689
1.66
85.55
4.4
3.2
e6/l
50.0
87.5
1.86
2092
13491
(3020779) Urea [Moles/volume] in Serum or Plasma
984
5163
2.04
84.51
10.1
8.5
mmol/l
8.6
8.8
0.39
945
4963
(3024139) IgG subclass 3 [Mass/volume] in Serum
256
683
3.84
83.22
1.5
1.4
g/l
0.4
0.4
0.33
125
507
(3027135) IgG subclass 1 [Mass/volume] in Serum
256
683
3.84
83.22
1.5
1.4
g/l
6.2
6.7
1.35
127
505
(3028192) IgG subclass 2 [Mass/volume] in Serum
256
684
3.84
83.05
1.5
1.4
g/l
2.5
2.8
1.69
126
508
(3000850) Epithelial cells [#/volume] in Urine
1886
12249
1.72
82.04
3.6
2.6
e6/l
5.6
6.0
0.92
1700
10710
(3021960) Folate [Moles/volume] in Serum or Plasma
1883
12230
1.72
81.87
1.7
1.5
nmol/l
19.9
20.4
0.69
1678
10598
(3030467) Casts [#/volume] in Urine by Automated count
2351
16239
1.65
80.71
4.2
3.1
e6/l
0.4
0.4
0.03
1914
12139
(3002173) Hemoglobin [Mass/volume] in Arterial blood
931
4870
2.04
80.39
9.4
8.4
g/l
123.7
122.2
1.22
899
4693
(3007164) IgA [Mass/volume] in Serum or Plasma
2016
13396
1.69
80.28
1.7
1.5
g/l
2.3
2.3
0.60
1286
8172
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2775
20049
1.61
78.98
4.0
3.3
u/l
33.5
34.3
0.21
2628
19076
(3019060) Gas panel - Arterial blood
697
3308
2.22
77.42
6.4
4.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
803
4030
2.11
77.37
6.0
4.8
mmol/l
1.8
1.6
1.36
618
2965
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
824
4180
2.09
77.16
6.1
4.8
kpa
5.2
5.1
0.34
787
3916
(3027945) Reticulocytes/100 erythrocytes in Blood
1093
6128
1.92
77.02
3.2
3.0
%
1.8
1.7
1.94
956
5476
(3009343) pH of Capillary blood
817
4139
2.09
76.76
6.1
4.8
ph
7.4
7.4
0.48
145
434
(3028026) IgM [Mass/volume] in Serum or Plasma
766
3802
2.13
75.91
2.0
1.9
g/l
1.2
1.3
0.55
719
3523
(4035726)
915
4860
2.00
75.43
1.5
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2191
15075
1.64
75.30
1.5
1.4
u/ml
1.2
1.9
3.07
637
3966
(3031040) Bacteria [#/volume] in Urine by Automated count
4744
39055
1.58
75.16
6.0
4.2
e6/l
932.2
1333.6
0.32
69
498
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1011
5592
1.93
73.99
4.6
3.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
286
890
3.30
73.56
2.6
1.9
mmol/l
1.7
1.7
0.45
278
870
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
612
2810
2.28
73.52
8.7
10.3
mmol/l
24.1
24.3
0.82
578
2638
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
867
4572
2.01
72.79
1.3
1.2
iu/ml
115.4
151.5
1.93
313
1688
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
118
185
6.46
71.72
2.3
1.6
nmol/l
0.1
0.2
1.10
94
131
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
312
1044
3.07
71.06
4.4
3.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2276
15995
1.61
70.86
4.2
3.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1015
5701
1.90
70.69
7.3
5.0
kpa
5.9
5.8
0.83
984
5535
(3026008) Bacteria identified in Urine by Culture
2330
16482
1.60
70.50
3.9
2.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1060
6052
1.87
70.13
2.2
1.7
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
74
67
11.14
70.03
3.4
2.0
nmol/l
22.5
1.9
2.00
68
61
(3035350) Ketones [Presence] in Urine by Test strip
3729
29354
1.54
69.93
4.7
3.4
estimate
0.0
0.0
1.28
1002
5436
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1744
11506
1.67
69.76
1.8
1.6
pmol/l
23498452.9
28708315.1
0.15
1498
9736
(3023520) Reticulocytes [#/volume] in Blood
841
4460
2.00
69.31
2.7
2.8
e9/l
73.2
69.4
2.13
634
3285
(3037467) Urinalysis macro (dipstick) panel - Urine
4928
41298
1.56
68.91
5.8
4.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
933
5140
1.93
68.78
5.5
3.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1062
6102
1.86
68.77
2.3
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
3761
29734
1.53
68.62
4.7
3.5
estimate
0.0
0.0
0.79
993
5441
(3012544) pH of Venous blood
1028
5862
1.87
68.14
7.2
4.9
ph
7.4
7.4
0.09
12
32
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
547
2478
2.30
67.69
2.0
1.9
u/l
39.0
39.5
0.19
501
2236
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1057
6096
1.85
67.55
4.1
4.4
u/l
244.9
244.2
0.03
999
5787
(3037522) Nuclear Ab [Titer] in Serum
1379
8616
1.73
67.19
1.5
1.4
titre
526.3
534.7
0.06
285
1708
(3002032) Base excess in Venous blood by calculation
1001
5684
1.88
67.17
7.4
5.0
mmol/l
1.9
1.8
0.56
842
4618
(3021601) Nitrite [Presence] in Urine by Test strip
3720
29427
1.52
67.08
6.2
4.7
estimate
0.0
0.0
0.59
1021
5581
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
345
1264
2.81
66.69
4.2
3.7
%
58.6
56.8
1.64
345
1264
(3000991) Gas panel - Venous blood
932
5183
1.91
66.66
10.4
9.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1393
8758
1.72
66.27
2.5
2.5
s
29.6
29.8
0.61
1349
8517
(3022806) Fractional oxyhemoglobin in Capillary blood
243
732
3.40
65.82
2.4
1.8
%
89.3
90.2
1.25
235
720
(3020630) Protein [Mass/volume] in Serum or Plasma
797
4220
1.99
65.81
2.8
2.5
g/l
65.7
66.7
3.04
741
3882
(3018095) Leukocytes [#/volume] in Urine
2807
20964
1.54
65.76
5.0
3.7
e6/l
63.1
87.9
1.90
2189
14586
(3029937) Albumin [Presence] in Urine by Test strip
2193
15519
1.58
65.16
5.1
3.8
estimate
0.0
0.0
0.31
995
5391
(3013512) EKG study
2159
15233
1.58
64.93
4.3
3.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
965
5506
1.86
63.55
2.7
2.5
g/l
0.2
0.2
0.63
900
5166
(3007853) Bacteria identified in Skin by Aerobe culture
1163
7050
1.77
62.61
2.3
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
878
4899
1.90
61.89
9.1
7.8
mmol/l
1.3
1.3
0.32
839
4690
(3008152) Bicarbonate [Moles/volume] in Arterial blood
633
3169
2.09
60.82
9.1
6.8
mmol/l
24.7
24.5
0.82
591
2941
(3024354) Oxygen [Partial pressure] in Venous blood
860
4808
1.89
60.16
6.8
4.6
kpa
4.6
4.8
1.55
832
4659
(3016244) Insulin [Units/volume] in Serum or Plasma
200
564
3.61
59.95
2.3
3.5
mu/l
21.2
27.1
1.47
189
536
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
380
1548
2.53
59.42
2.0
2.0
mg/l
9.0
11.0
4.35
353
1446
(3021901) Oxygen saturation in Capillary blood
283
992
2.92
59.32
3.9
3.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1909
13334
1.58
58.89
2.2
1.9
mg/l
1.1
1.1
0.20
1464
10023
(3009508) Creatinine [Moles/volume] in Urine
2376
17436
1.53
58.67
4.0
3.3
mmol/l
7.6
7.8
1.10
2051
14907
(3042936) Bacteria identified in Isolate by Culture
1269
8022
1.70
58.40
2.6
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
2246
16296
1.54
58.38
4.6
3.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
646
3307
2.04
58.35
2.5
2.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
356
1425
2.57
57.73
4.1
4.3
mmol/l
24.7
24.6
0.11
333
1254
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2944
22699
1.49
56.79
5.0
3.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
385
1627
2.44
55.61
1.4
1.7
mg/l
513.5
500.1
0.21
364
1548
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
635
3322
1.99
53.84
9.5
9.7
%
1.4
1.4
0.00
630
3301
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
6201
55879
1.63
53.83
19.5
11.6
ml/min/173m2
84.6
85.6
2.52
5479
45690
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
194
578
3.42
53.47
1.7
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
501
2417
2.15
52.84
1.5
1.5
u/ml
6.8
14.9
1.26
13
68
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
350
1452
2.48
52.60
1.4
1.7
mmol/l
3.7
3.7
0.13
320
1363
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6716
61930
1.81
52.17
22.2
12.8
mg/l
20.8
22.5
5.22
5697
48158
(3044290) Cell count panel - Cerebral spinal fluid
333
1355
2.52
52.15
1.5
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
6290
57003
1.64
51.94
5.2
4.1
mmol/l
5.9
5.8
1.92
5913
52590
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
429
1967
2.25
51.32
2.6
2.0
ug/l
1.8
2.3
0.53
388
1748
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
348
1462
2.45
50.88
1.6
1.8
e6/l
917.6
3984.8
0.63
284
1173
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
348
1462
2.45
50.88
1.5
1.8
e6/l
57.5
22.9
0.47
268
1110
(3015171) Extractable nuclear Ab [Units/volume] in Serum
492
2405
2.12
50.10
1.3
1.3
u/ml
0.7
1.0
0.26
49
214
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1425
9633
1.59
49.34
3.4
2.9
mmol/l
2.4
2.4
0.07
1249
8384
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
424
1966
2.22
49.34
8.4
7.7
mg/l
1.5
1.3
2.71
396
1862
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
360
1564
2.37
48.83
1.5
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
4687
40193
1.44
48.15
4.3
3.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1203
7849
1.63
48.10
1.3
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
373
1662
2.31
47.72
2.2
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
2064
15228
1.49
47.51
3.6
3.3
mg/l
540.9
380.1
0.68
1384
9718
(3036603) Volume of Urine
136
347
3.97
47.11
1.6
1.5
ml
1798.5
1953.8
0.35
20
69
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2089
15475
1.48
47.03
5.1
4.4
ug/l
2.4
2.8
0.23
1899
14003
(3027273) Bicarbonate [Moles/volume] in Venous blood
491
2462
2.06
46.67
5.2
3.7
mmol/l
25.0
25.3
0.86
469
2378
(3018405) Lactate [Moles/volume] in Arterial blood
390
1789
2.24
46.55
4.5
3.8
mmol/l
1.4
1.4
0.01
381
1761
(3025941) Bacteria identified in Stool by Culture
644
3568
1.88
45.79
1.4
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
747
4343
1.80
45.45
1.7
1.3
u/ml
319.9
224.5
0.71
702
4041
(3020891) Body temperature
430
2075
2.14
45.21
5.7
4.7
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
98
200
4.95
45.08
1.9
2.6
ng/l
120.1
130.4
0.21
82
135
(3004119) Hemoglobin [Mass/volume] in Venous blood
596
3238
1.91
44.99
6.7
4.0
g/l
130.4
129.7
0.28
579
3156
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
325
1401
2.38
44.85
2.1
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2047
15234
1.47
44.55
5.0
4.2
%
92.9
91.5
1.57
1994
14862
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
327
1420
2.36
44.38
2.0
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
6901
64640
1.84
44.23
21.3
11.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
454
2255
2.08
44.23
5.5
4.2
%
47.5
49.7
1.12
446
2225
(3046904) Somatotropin [Units/volume] in Serum or Plasma
48
5
96.59
43.78
3.3
1.2
mu/l
1.8
4.0
—
48
5
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
592
3238
1.90
43.74
1.7
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
396
1875
2.17
43.68
2.4
2.4
ug/l
413.4
609.6
0.71
370
1749
(3020682) Albumin/Creatinine [Ratio] in Urine
2123
15967
1.46
43.55
4.4
4.0
mg/mmol
10.9
10.8
0.03
1409
10260
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
226
829
2.78
43.55
1.9
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
299
1262
2.42
43.24
2.9
3.0
umol/l
33.1
35.0
0.66
245
1092
(3044640) Blood type and Crossmatch panel - Blood
2421
18705
1.43
42.83
3.0
2.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4816
41907
1.42
42.73
4.3
3.1
u/l
53.1
44.7
6.64
4555
39502
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
53
60
8.88
42.72
3.5
2.5
pmol/l
106.6
71.2
0.30
40
53
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
145
415
3.54
42.57
1.9
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
232
873
2.71
42.57
1.5
1.4
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
74
123
6.06
42.52
1.5
1.6
ug/l
0.4
0.4
0.24
51
80
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
162
500
3.29
42.26
1.7
1.3
pmol/l
69.1
133.0
0.51
96
151
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
404
1953
2.13
42.25
1.8
1.6
titre
144.2
375.8
2.14
26
77
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
255
1018
2.56
41.54
1.4
1.4
ug/l
3.8
4.6
0.52
229
915
(3020564) Creatinine [Moles/volume] in Serum or Plasma
6915
64989
1.82
41.30
25.3
14.3
umol/l
78.5
74.4
13.12
6910
64965
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
184
625
2.99
40.83
1.8
2.3
pg
32.1
32.6
0.77
184
619
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
257
1039
2.52
40.78
1.3
1.2
titre
46.7
230.5
—
6
19
(3000570) Elastase.pancreatic [Mass/mass] in Stool
355
1660
2.19
40.39
1.5
1.4
ug/g
264.1
288.4
1.40
208
931
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1995
15002
1.45
40.36
1.7
1.6
mmol/l
1.5
1.4
8.24
1715
12800
(3002385) Erythrocyte distribution width [Ratio]
5815
52595
1.47
40.03
26.1
15.6
%
13.7
13.6
13.25
5741
51530
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
415
2075
2.06
39.66
7.6
5.2
%
1.6
1.7
1.59
389
1939
(3026493) Urate [Moles/volume] in Serum or Plasma
1965
14791
1.44
39.36
3.0
2.6
umol/l
2287.7
3928.4
1.78
1714
13016
(3048689) Calprotectin [Mass/mass] in Stool
1221
8363
1.55
38.92
2.5
2.5
ug/g
141.9
122.9
0.84
980
6673
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
71
124
5.77
38.80
1.2
1.2
pmol/l
310.9
265.1
0.39
42
92
(3042631) Mycobacterium sp identified in Specimen
186
662
2.85
37.96
3.1
2.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
249
1028
2.47
37.79
2.0
1.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
293
1309
2.29
37.22
6.6
6.5
iu/ml
541.5
1871.7
0.55
32
185
(3022313) Gas panel - Capillary blood
558
3151
1.83
37.13
6.6
5.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
460
2444
1.94
36.97
5.9
3.7
%
0.7
0.7
0.22
449
2347
(3028626) Oxygen [Partial pressure] in Capillary blood
410
2094
2.01
36.93
7.6
5.5
kpa
9.0
9.1
0.45
397
1969
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3361
27952
1.37
36.68
4.9
4.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
403
2061
2.01
36.15
7.7
5.3
%
0.9
0.9
1.21
377
1933
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
383
1924
2.04
36.11
1.7
1.7
g/l
0.2
0.2
0.23
363
1826
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
188
693
2.76
35.93
1.9
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
190
709
2.72
35.47
1.9
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
277
1240
2.28
35.03
3.1
2.2
g/l
128.3
131.0
1.00
228
906
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
149
491
3.07
34.90
1.3
1.3
mmol/l
2.1
2.0
0.46
134
457
(40758558) Short blood count panel - Blood
2047
15800
1.41
34.81
8.4
7.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
388
1985
2.01
34.76
1.7
1.7
g/l
1.2
1.2
1.87
371
1886
(3016018) Differential panel - Cerebral spinal fluid
191
726
2.67
34.40
1.6
1.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
239
1014
2.40
34.19
4.6
4.4
u/ml
28077.7
1158.3
0.46
19
68
(3011412) CD3 cells [#/volume] in Blood
188
713
2.68
34.01
2.6
2.7
e9/l
1.3
1.2
0.16
128
448
(3023419) Bacteria identified in Sputum by Culture
174
639
2.76
33.51
4.0
2.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
160
562
2.89
33.49
2.7
2.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
307
1460
2.15
33.46
3.7
3.3
mg/l
57.2
92.8
0.41
222
1178
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1006
6841
1.54
32.65
3.6
3.1
umol/l
6.8
7.5
0.53
838
5899
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
503
2864
1.81
32.49
12.2
10.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
297
1418
2.14
32.04
3.7
3.3
ratio
1.4
2.1
0.78
24
119
(3043409) Potassium [Moles/volume] in Arterial blood
311
1516
2.10
31.79
5.1
4.0
mmol/l
3.8
3.9
1.50
292
1420
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6882
65210
1.67
31.69
14.4
9.7
u/l
29.6
26.7
3.44
6731
63121
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
302
1459
2.11
31.60
3.8
3.4
mg/l
29.8
56.8
1.97
217
1178
(3004809) Band form neutrophils/100 leukocytes in Blood
212
885
2.43
31.45
3.6
3.5
%
1.3
1.5
0.21
174
672
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
204
840
2.47
31.18
1.9
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
137
462
3.00
30.87
1.6
1.3
u/ml
1.3
0.7
0.46
74
183
(3000494) Fungus identified in Specimen by Culture
1011
6972
1.52
30.61
1.8
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
161
598
2.73
30.37
2.5
2.5
%
75.2
71.1
2.92
153
581
(3037756) Immunofixation for Serum or Plasma
221
956
2.35
30.29
1.6
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
200
828
2.45
30.22
1.2
1.2
u/l
33.5
42.2
0.22
176
719
(3012565) Volume of 24 hour Urine
102
291
3.54
30.19
2.0
2.3
ml
2312.4
2039.5
0.87
94
266
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
310
1541
2.05
30.07
1.7
1.9
iu/l
34.0
4.5
0.48
102
577
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
498
2898
1.77
29.84
7.2
5.0
mmol/l
24.8
24.6
0.87
470
2759
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
100
284
3.55
29.81
2.0
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
574
3480
1.70
29.72
8.5
5.6
mmol/l
24.3
24.0
1.16
532
3219
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
99
280
3.57
29.69
2.0
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
241
1094
2.24
29.50
3.6
3.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2873
23856
1.33
29.45
2.2
2.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
225
999
2.29
29.04
1.9
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
934
6401
1.52
29.02
1.4
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
157
590
2.69
28.97
2.5
2.5
%
11.8
12.4
0.25
86
352
(3007566) Smooth muscle Ab [Titer] in Serum
336
1746
1.97
28.78
1.3
1.4
titre
132.6
132.1
0.00
31
163
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
106
323
3.31
28.34
1.9
1.5
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
98
289
3.42
27.60
1.8
1.7
mmol/24h
6.1
7.0
—
6
23
(3026389) Candida sp identified in Specimen by Organism specific culture
201
875
2.33
27.18
1.5
1.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
55
107
5.17
26.82
1.4
1.1
umol/24h
28.3
0.7
0.49
26
53
(3009466) Valproate [Moles/volume] in Serum or Plasma
210
938
2.27
26.75
6.5
5.1
umol/l
374.8
375.6
0.02
191
828
(3034770) Mitochondria Ab [Titer] in Serum
327
1730
1.93
26.57
1.3
1.3
titre
955.6
965.2
—
9
52
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1260
9322
1.42
26.23
3.7
2.9
e6/l
3.4
2.7
1.49
749
4991
(3017143) Hepatitis C virus Ab [Presence] in Serum
1121
8136
1.44
25.91
1.8
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
314
1657
1.93
25.71
3.1
2.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
103
328
3.17
25.67
1.8
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
169
700
2.45
25.56
1.2
1.1
au/ml
85.4
64.3
—
5
7
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
405
2329
1.78
25.24
1.8
1.8
g/l
1.5
1.5
0.29
351
2002
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1814
14348
1.35
24.95
2.9
2.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
54
111
4.89
24.75
1.6
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
232
1119
2.11
24.43
1.7
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
143
562
2.57
24.19
1.2
1.2
u/l
66.1
81.0
0.62
110
386
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
47
88
5.36
23.93
1.8
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
188
841
2.27
23.90
1.3
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
154
636
2.45
23.48
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6051
56532
1.36
23.43
4.5
3.7
mmol/l
1.4
1.3
32.12
5657
52551
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
175
767
2.31
23.35
1.8
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
504
3153
1.64
23.04
1.9
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
805
5600
1.49
22.99
1.3
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
658
4397
1.54
22.73
2.5
2.4
au/ml
27.7
22.3
0.33
27
275
(3047181) Lactate [Moles/volume] in Blood
304
1658
1.87
22.53
9.2
6.0
mmol/l
1.3
1.3
0.39
265
1458
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
6265
58956
1.38
22.35
5.0
4.1
mmol/l
4.6
4.7
14.65
5898
55338
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
6228
58563
1.37
22.23
4.9
4.0
mmol/l
1.4
1.5
25.31
5835
54722
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1363
10485
1.37
22.08
1.4
1.3
iu/ml
28.6
29.3
0.06
378
3259
(3004451) EKG impression Narrative
80
240
3.36
22.01
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
6337
59776
1.38
22.00
5.3
4.4
mmol/l
2.7
2.8
11.75
5943
55752
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
308
1700
1.85
21.99
1.4
1.3
u/ml
39.5
34.2
0.10
15
100
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1298
9916
1.37
21.95
3.5
2.7
e6/l
1.3
1.1
0.34
788
5554
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
251
1296
1.97
21.94
1.3
1.3
u/ml
23.8
40.1
1.64
24
129
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
93
308
3.04
21.75
1.3
1.3
%
56.1
67.7
—
8
38
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
608
4032
1.55
21.71
1.4
1.3
au/ml
41.8
49.4
0.35
24
170
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
501
3176
1.62
21.70
2.4
2.3
u/l
4597.0
6001.9
0.56
152
1207
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
166
738
2.28
21.45
7.4
6.9
mg/l
11.9
11.2
1.03
150
692
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
284
1547
1.87
21.14
1.4
1.3
u/ml
2.3
6.2
1.13
25
150
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
286
1568
1.86
20.87
1.4
1.3
u/ml
7.9
8.5
0.06
39
247
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
133
550
2.44
20.27
2.6
2.9
e6/l
527.9
496.7
0.30
107
452
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
119
467
2.57
20.26
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
746
5237
1.47
20.25
5.2
4.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
161
726
2.24
20.14
1.7
2.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
101
368
2.77
19.91
1.6
1.5
u/l
6.7
6.2
0.13
89
316
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
128
525
2.46
19.87
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
101
369
2.76
19.81
1.2
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
143
618
2.34
19.77
4.4
4.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
147
644
2.31
19.70
7.3
15.5
mmol/l
7.5
7.1
0.57
123
542
(3039162) Centromere protein B Ab [Units/volume] in Serum
168
779
2.18
19.64
1.3
1.3
u/ml
41.8
51.4
0.21
12
46
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
76
238
3.21
19.56
4.8
4.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
239
1264
1.92
19.50
1.3
1.3
u/ml
2.4
4.3
0.48
18
89
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
129
538
2.42
19.33
2.6
2.9
e9/l
0.2
0.2
0.02
108
449
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
97
352
2.78
19.28
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1354
10602
1.34
19.23
4.5
3.5
ng/l
425.8
522.9
0.25
950
7655
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
209
1063
1.99
19.12
1.2
1.1
iu/ml
25.6
8965.4
0.57
61
272
(21494815) CD4 cells/100 lymphocytes in Specimen
144
634
2.29
19.09
2.4
2.7
%
36.2
43.2
—
9
62
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
300
1719
1.78
18.95
3.5
4.4
u/ml
0.3
0.3
0.37
182
979
(3037121) Protein [Mass/volume] in Urine
345
2058
1.71
18.91
3.9
3.8
g/l
0.3
0.3
0.93
184
988
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
325
1911
1.73
18.76
1.8
1.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
522
3459
1.55
18.66
1.1
1.2
titre
119.3
218.8
—
7
112
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
27
37
7.32
18.62
3.1
2.6
pmol/l
347.2
17.5
—
7
13
(46235355) HIV 1 and 2 tests - Meaningful Use set
1688
13698
1.30
18.45
2.0
1.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
616
4239
1.49
18.43
3.4
3.0
ng/l
140.8
178.9
2.28
553
3819
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
108
424
2.57
18.41
10.1
12.1
mmol/l
0.6
0.6
0.06
96
387
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
62
181
3.44
17.87
2.4
2.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
130
566
2.32
17.72
1.2
1.1
mg/l
39.1
38.9
0.02
99
471
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
369
2282
1.65
17.64
2.3
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
300
1756
1.74
17.62
3.4
3.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
873
6469
1.39
17.49
22.4
21.9
inr
1.2
1.3
0.30
119
991
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1265
9942
1.33
17.33
1.4
1.3
u/ml
7.0
10.5
1.77
499
3992
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
341
2077
1.67
17.30
2.1
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
373
2325
1.63
17.29
1.8
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
7154
69488
1.63
17.25
32.6
18.8
e9/l
260.0
255.6
6.39
7049
67752
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
315
1880
1.70
17.25
3.0
2.2
g/l
3.7
3.8
0.91
225
1366
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
315
1880
1.70
17.25
3.0
2.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
144
663
2.19
17.18
1.1
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
315
1882
1.70
17.18
3.0
2.2
g/l
7.3
7.4
0.06
230
1434
(3030981) Hyaline casts [#/volume] in Urine by Automated count
436
2835
1.57
16.95
3.4
2.7
e6/l
0.3
0.3
0.24
430
2752
(3039000) Anion gap in Blood
216
1159
1.89
16.92
11.2
7.1
mmol/l
11.3
11.3
0.06
195
1038
(3018572) Chloride [Moles/volume] in Blood
216
1160
1.89
16.87
11.2
7.1
mmol/l
104.6
105.2
0.74
195
1039
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
441
2881
1.56
16.79
1.1
1.1
u/ml
1.1
12.2
—
7
36
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
108
446
2.44
16.59
2.5
3.5
%
100.1
95.9
0.58
103
420
(3035941) MCH [Entitic mass]
7154
69537
1.62
16.58
32.4
18.7
pg
30.0
30.2
5.31
7102
68646
(3024731) MCV [Entitic volume]
7154
69540
1.62
16.54
32.4
18.7
fl
90.3
90.4
0.51
7103
68650
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1524
12357
1.29
16.51
4.2
3.8
%
22.4
21.8
0.76
665
5457
(3026361) Erythrocytes [#/volume] in Blood
7154
69551
1.61
16.39
32.6
18.8
e12/l
4.5
4.5
0.15
7039
67649
(21494814) CD8 cells/100 lymphocytes in Specimen
70
233
3.02
16.33
2.2
2.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
7155
69568
1.61
16.32
32.6
18.8
e9/l
7.0
6.7
18.85
7036
67648
(3000963) Hemoglobin [Mass/volume] in Blood
7154
69568
1.61
16.16
32.8
18.9
g/l
135.2
135.9
3.68
7101
68683
(3008037) Lactate [Moles/volume] in Venous blood
199
1057
1.91
16.09
4.7
3.1
mmol/l
1.5
1.5
0.23
193
1030
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
296
1772
1.70
16.04
3.0
2.2
g/l
3.0
3.1
0.78
230
1401
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
123
549
2.26
15.86
1.1
1.1
mg/l
271.8
249.6
0.27
98
479
(21494755) Public health laboratory ask at order entry panel
502
7196
0.68
15.73
1.3
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
233
1312
1.80
15.67
1.4
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
35
74
4.74
15.60
1.3
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
67
224
3.01
15.53
2.3
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
612
4354
1.44
15.38
3.2
2.3
ug/l
6.0
7.3
0.94
519
3825
(3045716) Anion gap in Serum or Plasma
69
236
2.94
15.37
2.3
2.4
mmol/l
8.9
9.2
0.41
54
177
(3006653) Thiamine [Moles/volume] in Blood
77
280
2.77
15.33
1.3
1.3
nmol/l
135.9
137.0
0.08
77
280
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
91
362
2.53
15.17
1.2
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
288
1742
1.68
15.04
3.1
2.2
g/l
9.5
10.4
2.98
246
1493
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
220
1236
1.80
14.92
1.4
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1066
8340
1.32
14.89
1.9
1.8
%
1.5
1.4
2.61
912
7451
(40768443) Skin Pathology biopsy report
378
2451
1.57
14.89
1.3
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
270
1610
1.70
14.87
3.2
2.2
g/l
0.5
0.9
2.04
235
1407
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
107
463
2.33
14.86
15.2
19.6
nmol/l
1437.7
3495.4
0.50
102
449
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
91
366
2.50
14.84
2.7
2.8
%
29.5
26.6
1.10
86
356
(3014271) Vancomycin [Susceptibility]
65
221
2.96
14.65
2.9
2.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
323
2029
1.62
14.54
3.7
3.5
g/l
3.5
3.5
0.00
305
1933
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
71
255
2.80
14.49
1.1
1.1
ng/l
724.2
312.6
0.55
21
55
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
222
1262
1.78
14.49
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
222
1262
1.78
14.49
1.4
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
220
1252
1.78
14.31
1.5
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
345
2211
1.59
14.30
2.9
3.5
%
94.8
92.5
1.02
323
2073
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
195
1071
1.84
14.26
1.6
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
163
845
1.95
14.22
1.5
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
706
5221
1.39
14.21
1.5
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
72
264
2.74
14.15
1.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
89
363
2.47
14.11
1.1
1.1
nmol/l
1.5
11.0
1.31
20
76
(3024928) Oxygen saturation in Venous blood
216
1230
1.78
14.03
8.2
4.6
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
93
389
2.41
13.97
2.8
3.0
%
11.7
13.0
0.44
84
376
(3028707) Methadone [Presence] in Urine by Screen method
248
1471
1.71
13.95
5.7
2.9
—
—
—
0
0
(4027681)
102
446
2.30
13.86
1.5
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
313
1982
1.60
13.65
3.5
3.3
%
177.4
181.3
0.35
302
1894
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
240
1428
1.70
13.36
3.1
2.1
g/l
0.0
0.0
1.51
226
1320
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
136
680
2.02
13.18
1.8
1.7
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
70
263
2.68
13.15
1.2
1.1
u/l
106.5
86.6
0.43
51
208
(3036489) Thrombin time
370
2456
1.53
13.14
2.8
2.9
s
21.2
21.6
0.68
319
2147
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
108
498
2.18
12.95
1.3
1.3
nmol/l
1.6
1.4
0.84
100
452
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
69
261
2.66
12.81
1.2
1.1
u/l
47.7
25.3
0.50
48
201
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
27
55
4.92
12.59
1.4
1.1
umol/24h
15.4
1.7
0.50
27
55
(3002256) Pathology report gross observation
944
7440
1.31
12.37
1.3
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
34
85
4.01
12.33
4.0
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1525
12756
1.24
12.27
4.7
3.8
kg/l
1.0
1.0
0.65
240
1912
(3016650) Hepatitis A virus Ab [Presence] in Serum
190
1088
1.76
12.16
1.1
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
736
5616
1.34
12.10
3.0
2.5
u/l
34.7
45.5
0.64
628
4815
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
54
185
2.93
12.08
1.2
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
81
341
2.39
12.05
1.6
1.5
u/l
7.1
5.7
0.32
44
173
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
125
628
2.01
12.00
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
90
398
2.28
11.97
1.8
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
855
6679
1.32
11.94
9.6
6.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
121
602
2.03
11.93
1.9
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
211
1255
1.70
11.81
2.2
2.3
nmol/l
1.0
0.8
2.29
181
1065
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
210
1249
1.70
11.76
2.6
2.4
ug/min
121.9
112.2
0.08
127
780
(44790048)
141
744
1.91
11.75
2.0
1.6
—
—
—
0
0
(44806118)
141
744
1.91
11.75
2.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
48
158
3.05
11.52
2.1
2.3
umol/l
15.6
16.7
0.28
48
158
(3019420) Tryptase [Mass/volume] in Serum or Plasma
83
361
2.31
11.50
1.8
1.5
ug/l
11.3
7.7
0.38
74
315
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
86
380
2.28
11.48
1.2
1.1
u/l
1.1
1.1
0.22
45
176
(44790049)
140
744
1.90
11.43
2.0
1.6
—
—
—
0
0
(44790047)
140
744
1.90
11.43
2.0
1.6
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
26
56
4.65
11.38
3.9
2.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
63
243
2.60
11.30
2.1
2.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
114
567
2.02
11.28
3.5
2.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
98
461
2.14
11.24
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1104
8986
1.27
11.17
3.1
2.8
ug/l
0.7
0.7
0.10
713
5551
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1347
11218
1.24
11.16
1.8
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
258
1640
1.59
11.14
1.4
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
132
696
1.91
11.05
1.2
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
76
324
2.36
11.03
1.3
1.2
u/l
27.4
22.6
0.42
66
277
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
217
1326
1.65
10.99
3.2
2.1
g/l
0.0
0.0
0.00
204
1224
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
78
337
2.33
10.99
1.3
1.2
u/l
85.7
95.1
0.39
70
292
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
215
1311
1.66
10.98
3.2
2.1
g/l
0.0
0.0
0.00
204
1223
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
37
107
3.47
10.94
2.1
3.1
mg/l
37.3
40.0
—
6
29
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
102
495
2.07
10.80
1.9
1.5
%
31.5
32.9
0.13
65
295
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
31
80
3.88
10.80
5.1
6.0
ug/min
60.9
43.5
0.67
22
61
(3038515) Glucose [Moles/volume] in Venous blood
172
994
1.75
10.72
5.2
3.1
mmol/l
7.4
7.4
0.05
167
971
(3004775) Volume in Urine collected for unspecified duration
88
405
2.19
10.68
2.3
2.3
ml
705.4
629.9
0.74
64
276
(3049717) Cytology report of Urine Cyto stain
268
1737
1.56
10.66
2.5
2.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
49
171
2.88
10.65
1.2
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
234
1471
1.61
10.60
3.1
2.0
g/l
37.3
38.0
0.84
212
1283
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
224
1394
1.62
10.57
1.6
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
78
343
2.29
10.57
26.1
27.8
ug/l
106.4
124.8
1.68
65
295
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
123
645
1.92
10.49
1.9
1.6
%
56.0
55.6
0.04
82
404
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
29
73
3.98
10.45
1.3
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
71
302
2.36
10.39
1.6
1.6
nmol/l
1.8
1.3
1.69
55
234
(3028679) Herpes simplex virus Ab [Presence] in Serum
81
365
2.23
10.37
1.1
1.2
—
—
—
0
0
(4010399)
544
4059
1.37
10.34
1.5
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
21
41
5.13
10.28
2.0
1.7
umol/l
48.2
44.7
0.16
21
41
(40761535) Cells panel - Urine sediment
589
4454
1.35
10.26
4.3
3.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
25
57
4.39
10.23
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
73
319
2.30
10.06
2.7
3.0
e6/l
270.2
234.9
0.31
40
200
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
52
195
2.68
9.90
1.3
1.2
%
24.0
20.0
—
7
24
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
302
2043
1.50
9.88
1.7
1.6
iu/ml
0.1
3.7
0.69
63
428
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
50
184
2.73
9.87
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
50
184
2.73
9.87
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
233
1491
1.58
9.82
1.6
1.6
—
—
—
0
0
(3016750) Collection duration of Urine
70
304
2.31
9.79
2.3
2.2
min
515.9
494.0
0.84
55
229
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
148
843
1.77
9.74
2.3
3.1
u/ml
104.1
563.7
0.68
141
785
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
15
22
6.83
9.71
1.5
1.4
%
1.6
1.4
1.02
15
22
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
393
2806
1.42
9.71
2.4
2.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
825
6587
1.28
9.70
4.7
4.1
%
31.4
32.0
0.83
625
4604
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
116
615
1.90
9.61
1.4
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
49
182
2.70
9.52
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
323
2232
1.47
9.51
8.1
3.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
18
33
5.46
9.43
9.6
4.9
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
29
79
3.68
9.40
1.6
1.2
%
30.4
61.8
2.45
14
34
(3011397) Hemoglobin [Presence] in Urine by Test strip
1609
13862
1.20
9.36
4.2
3.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
95
475
2.01
9.34
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
114
607
1.89
9.34
3.8
4.7
u/ml
143.4
70.4
0.43
34
173
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
66
287
2.31
9.23
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
100
512
1.96
9.20
2.4
2.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
177
1080
1.65
9.09
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
61
258
2.37
9.09
1.7
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
594
4579
1.32
9.08
2.9
2.6
ml/min/173m2
67.9
69.6
0.44
257
1756
(3000012) Reticulocyte production index
64
277
2.32
9.05
1.3
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
41
143
2.88
8.97
1.3
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
215
1383
1.57
8.90
1.6
1.6
u/ml
101.7
111.6
0.69
49
250
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
51
201
2.55
8.84
1.1
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
71
325
2.19
8.81
1.5
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
59
251
2.36
8.69
3.3
3.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
93
476
1.96
8.60
2.8
2.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
79
382
2.08
8.54
3.3
2.7
ug/l
27.8
29.4
—
5
5
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
14
22
6.37
8.51
1.2
1.1
u/field
1.2
1.1
—
9
16
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
42
153
2.75
8.50
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
100
527
1.91
8.49
1.2
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
274
1887
1.47
8.26
1.1
1.1
u/ml
4.7
7.2
0.48
22
246
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
76
368
2.07
8.21
2.6
2.6
%
42.9
40.8
0.35
37
117
(1001926) Buprenorphine [Presence] in Urine by Screen method
360
2610
1.40
8.19
4.9
2.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
101
543
1.87
8.09
1.4
1.5
promille
1.3
1.3
0.01
76
425
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4759
45000
1.16
8.05
3.5
3.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
68
319
2.14
7.98
1.1
1.1
u/ml
2.0
18.7
—
6
30
(3017732) Neutrophils [#/volume] in Blood
546
4241
1.31
7.92
3.1
2.7
e9/l
4.3
4.2
0.64
416
3431
(3017354) Segmented neutrophils/100 leukocytes in Blood
99
533
1.87
7.91
3.7
3.4
%
59.9
57.5
0.45
66
327
(3026250) Tacrolimus [Mass/volume] in Blood
71
342
2.08
7.79
47.5
37.2
ug/l
6.8
7.3
1.97
66
316
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
13
21
6.20
7.70
1.8
1.2
nmol/l
671.3
424.0
0.50
13
21
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
53
228
2.33
7.66
1.1
1.1
%
100.4
88.4
2.63
22
110
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
67
319
2.11
7.59
1.5
1.3
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
41
157
2.62
7.58
1.4
1.4
nmol/l
89.3
124.9
1.32
34
117
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
58
261
2.23
7.56
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
191
1245
1.55
7.53
5.7
4.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
28
87
3.22
7.49
1.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
34
119
2.86
7.45
1.8
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
496
6337
0.77
7.41
1.6
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
38
142
2.68
7.38
1.4
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
84
439
1.92
7.37
1.1
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
13
22
5.91
7.36
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
88
468
1.89
7.33
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
84
443
1.91
7.19
1.1
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
30
100
3.01
7.16
1.1
1.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
28
90
3.12
7.11
2.7
2.4
umol/l
1.2
1.2
0.14
28
84
(3045142) Bone marrow Pathology biopsy report
107
611
1.76
7.10
1.5
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
55
249
2.22
7.09
1.5
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
58
269
2.16
7.05
1.0
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
50
218
2.30
7.04
1.3
1.2
%
114.7
109.2
0.85
45
193
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
34
123
2.77
7.03
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
118
696
1.71
6.99
1.7
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
96
534
1.81
6.96
2.5
2.8
e6/l
651.7
717.8
0.46
37
177
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
27
86
3.15
6.96
2.0
1.6
—
—
—
0
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
25
76
3.29
6.94
1.8
1.8
mg/l
3.3
2.7
0.15
16
59
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
25
76
3.29
6.94
1.8
1.8
mg/l
1.7
1.5
0.10
15
59
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
25
76
3.29
6.94
1.8
1.8
mg/l
1.7
2.5
0.33
14
59
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
25
76
3.29
6.94
1.8
1.8
mg/l
0.5
1.4
1.90
16
54
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
25
76
3.29
6.94
1.8
1.8
mg/l
3.6
4.3
0.21
15
54
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
25
76
3.29
6.94
1.8
1.8
mg/l
3.6
4.6
0.35
13
54
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
25
76
3.29
6.94
1.8
1.8
mg/l
1.9
1.4
0.22
11
53
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
25
76
3.29
6.94
1.8
1.8
mg/l
1.1
1.6
0.49
14
60
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
25
76
3.29
6.94
1.8
1.8
mg/l
0.9
0.9
0.02
15
56
(3045424) Erythrocytes [Presence] in Urine
154
976
1.59
6.89
1.6
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
62
298
2.09
6.89
2.5
2.4
umol/l
199.6
179.5
0.10
33
162
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
136
838
1.63
6.83
1.2
1.1
g/l
1.6
1.5
0.99
127
756
(3034891) Synovial lining cells/100 cells in Synovial fluid
56
260
2.16
6.80
1.9
1.4
%
1.7
4.0
1.42
12
60
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
117
694
1.70
6.80
1.7
1.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
93
517
1.81
6.77
1.1
1.0
mg/l
308.9
286.4
1.76
85
468
(3048929) Epstein Barr virus Ab [Presence] in Serum
347
2586
1.36
6.73
1.4
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
51
229
2.23
6.73
1.1
1.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
25
78
3.21
6.67
1.8
1.8
mg/l
1.2
1.1
0.08
16
55
(3052592) Norovirus Ag [Presence] in Stool
28
94
2.98
6.63
1.3
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
28
94
2.98
6.63
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
116
692
1.69
6.62
1.7
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
151
963
1.58
6.60
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
356
2673
1.35
6.58
4.5
3.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
119
716
1.67
6.58
1.6
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
49
219
2.24
6.54
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
48
213
2.26
6.52
1.3
1.3
—
—
—
0
0
(4306422)
156
1006
1.56
6.51
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
117
703
1.67
6.50
1.7
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
117
704
1.67
6.47
1.7
1.5
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
65
326
2.00
6.47
2.9
2.4
umol/l
60.7
52.9
0.86
54
284
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
155
1000
1.56
6.46
1.3
1.3
u/ml
8.6
4.0
1.32
70
429
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
52
241
2.16
6.37
1.3
1.2
g/l
0.3
0.3
1.58
38
196
(3019977) pH of Arterial blood
57
275
2.08
6.31
2.5
3.1
ph
7.4
7.4
0.15
25
88
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
150
967
1.56
6.28
1.2
1.1
%
122.5
115.9
1.61
135
877
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
250
1789
1.41
6.23
1.3
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
81
446
1.82
6.13
1.5
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
87
490
1.78
6.11
4.1
3.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
251
1806
1.40
6.07
1.3
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
53
253
2.10
6.05
1.2
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
48
221
2.18
6.00
1.0
1.2
%
106.5
85.7
2.38
19
108
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
81
450
1.81
5.96
1.5
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
74
400
1.86
5.95
1.1
1.2
ratio
1.1
1.1
0.46
24
145
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
32
123
2.61
5.94
1.6
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
156
1029
1.53
5.92
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
74
3.11
5.87
1.2
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
47
217
2.17
5.84
1.1
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
45
3.78
5.80
1.3
1.1
—
—
—
0
0
(4198724)
74
404
1.84
5.77
1.7
2.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
250
1817
1.39
5.72
1.3
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
19
55
3.46
5.71
1.1
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
138
2.47
5.67
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
44
202
2.18
5.56
1.5
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
57
289
1.98
5.56
2.0
1.6
u/field
0.6
3.3
2.99
40
212
(3045414) Leukocytes [Presence] in Urine
342
2622
1.32
5.53
1.8
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
397
3106
1.29
5.53
4.5
2.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
48
229
2.10
5.52
1.1
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
74
411
1.81
5.49
2.6
2.1
u/field
1.1
1.8
1.39
36
178
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
34
141
2.42
5.43
1.1
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
25
91
2.75
5.18
1.4
1.5
nmol/l
21.2
13.3
—
5
25
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
295
2237
1.33
5.18
1.4
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
24
86
2.79
5.12
1.4
1.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
183
1287
1.43
5.10
1.8
1.6
e6/l
9766.1
12140.7
0.50
134
920
(40768441) Liver Pathology biopsy report
79
458
1.73
5.10
1.5
1.5
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
10
19
5.27
5.03
1.3
1.2
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
12
27
4.45
5.02
1.6
1.1
mg/l
0.1
0.0
0.70
12
19
(3024891) Influenza virus A+B Ag [Presence] in Specimen
249
1850
1.36
5.02
1.2
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
46
225
2.05
4.99
3.2
2.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
81
476
1.71
4.99
1.9
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
81
476
1.71
4.99
1.9
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
81
476
1.71
4.99
1.9
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
207
1495
1.39
4.97
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
419
3350
1.26
4.94
4.5
2.1
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
20
66
3.03
4.93
1.8
1.7
mmol/l
160.8
170.8
0.15
20
61
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
222
1625
1.38
4.92
1.5
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
24
89
2.70
4.82
1.7
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
47
235
2.00
4.82
1.6
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
47
235
2.00
4.82
1.6
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
420
3374
1.26
4.77
4.6
2.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
150
1030
1.46
4.77
1.3
1.2
u/ml
3.9
3.7
0.04
45
345
(3027008) Opiates [Presence] in Urine
419
3366
1.26
4.76
4.4
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
341
4312
0.78
4.75
1.4
1.4
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
52
3.27
4.73
7.1
8.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
35
158
2.22
4.66
1.1
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
19
63
3.02
4.65
1.3
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1561
14087
1.14
4.64
1.7
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
21
74
2.84
4.64
11.6
12.1
mmol/l
4.9
5.8
1.04
21
74
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
29
4.14
4.61
2.0
3.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
26
103
2.53
4.61
1.8
2.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
144
990
1.46
4.56
1.8
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
84
513
1.64
4.52
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
84
513
1.64
4.52
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
84
514
1.64
4.49
1.1
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
46
235
1.96
4.47
2.4
2.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
84
516
1.63
4.42
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
84
516
1.63
4.42
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
84
517
1.63
4.39
1.1
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
18
60
3.00
4.38
1.3
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
23
88
2.62
4.38
1.3
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
48
251
1.92
4.37
2.3
2.3
nmol/l
166.7
155.3
0.31
43
213
(3051651) Icteric interference index of Serum or Plasma
68
397
1.72
4.34
4.3
3.8
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
27
113
2.39
4.29
1.2
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
25
101
2.48
4.28
3.0
4.7
—
—
—
0
0
(3035880) pH of Pleural fluid
47
246
1.92
4.27
1.2
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
209
1554
1.35
4.25
1.5
1.4
u/ml
263.5
251.8
0.23
147
938
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
35
167
2.10
4.11
1.4
1.5
%
61.8
62.5
0.04
27
135
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
19
68
2.80
4.11
6.3
5.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
37
181
2.05
4.07
1.5
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
69
413
1.68
4.05
1.2
1.3
u/l
355.8
362.5
0.04
63
397
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
306
3840
0.79
4.04
1.4
1.5
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
14
42
3.34
4.03
1.1
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
23
92
2.50
4.03
1.3
1.7
ng/l
98.2
134.7
1.03
23
92
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
19
69
2.76
4.00
6.4
5.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
17
58
2.93
4.00
1.1
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
62
362
1.72
3.99
5.8
6.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
33
156
2.12
3.97
2.3
1.6
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
11
28
3.93
3.97
1.0
1.1
pmol/l
77.6
223.2
—
5
18
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
608
5174
1.19
3.96
3.3
4.0
ug/l
36.6
28.1
0.20
480
4096
(40768446) Kidney Pathology biopsy report
52
289
1.80
3.95
2.4
1.8
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
55
312
1.77
3.91
1.9
2.8
umol/l
64.7
51.6
—
8
34
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
37
184
2.01
3.91
2.5
3.1
—
—
—
0
0
(4268621)
104
693
1.51
3.91
2.5
2.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
53
298
1.78
3.89
1.0
1.1
%
103.6
93.1
1.20
45
236
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
24
100
2.40
3.87
1.2
1.1
pmol/l
2.6
5.6
—
5
14
(3016273) Islet cell 512 Ab [Units/volume] in Serum
21
82
2.56
3.87
1.1
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
404
3317
1.23
3.83
3.4
2.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
32
152
2.11
3.82
7.7
7.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
28
126
2.23
3.81
1.3
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
28
126
2.23
3.81
1.3
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
28
126
2.23
3.81
1.3
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
28
126
2.23
3.81
1.3
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
125
869
1.44
3.81
1.5
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
77
483
1.60
3.79
1.1
1.1
nmol/l
367.5
378.2
0.16
62
433
(3036782) Glucose [Moles/volume] in Pleural fluid
73
452
1.62
3.78
1.2
1.4
mmol/l
6.5
6.4
0.10
68
422
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
14
44
3.18
3.76
1.2
1.1
u/l
1.6
5.3
—
7
8
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
13
39
3.34
3.75
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
310
2481
1.26
3.71
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
260
2037
1.29
3.70
1.3
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
86
557
1.55
3.70
1.3
1.4
mmol/l
11.6
11.5
0.06
38
131
(3003338) MCHC [Mass/volume]
5330
54762
0.91
3.67
27.0
16.2
g/l
332.6
333.0
2.58
5297
54355
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
50
282
1.78
3.65
2.6
3.5
au/ml
186.1
123.3
0.39
11
38
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
9
16
5.63
3.65
1.1
1.1
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
9
16
5.63
3.65
1.7
2.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
67
410
1.64
3.65
2.0
1.4
umol/l
56.7
70.0
—
6
41
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
55
320
1.72
3.61
1.1
1.1
miu/ml
1433.9
1460.6
0.06
55
320
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
147
1066
1.39
3.56
1.1
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
92
611
1.51
3.55
1.4
1.5
g/l
30.1
33.5
1.45
86
556
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
32
157
2.04
3.54
1.7
1.4
%
111.5
101.3
1.36
32
149
(1002224) Polysomnography panel
339
2761
1.24
3.49
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2412
22615
1.10
3.42
3.2
2.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
58
2.76
3.41
1.3
1.1
—
—
—
0
0
(4024509)
78
505
1.55
3.39
1.6
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
249
1966
1.27
3.37
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
68
431
1.58
3.25
1.1
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
40
219
1.83
3.25
2.3
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
40
219
1.83
3.25
2.3
2.0
—
—
—
0
0
(4038314)
13
43
3.02
3.24
1.4
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
24
109
2.20
3.24
1.2
1.2
ug/l
329.4
366.5
0.03
12
55
(3023420) DNA double strand Ab [Units/volume] in Serum
98
674
1.46
3.22
1.8
1.5
iu/ml
32.8
23.8
—
5
28
(3004616) Nuclear Ab [Presence] in Serum
102
708
1.45
3.20
1.6
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
48
280
1.72
3.17
2.1
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
48
280
1.72
3.17
2.1
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
48
280
1.72
3.17
2.1
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
48
280
1.72
3.17
2.1
1.9
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
30
151
1.99
3.13
1.0
1.1
%
85.0
78.6
—
5
38
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
40
222
1.80
3.13
2.3
2.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
22
98
2.25
3.11
1.3
1.5
nmol/l
12.7
472506.8
1.08
16
80
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
958
8592
1.13
3.11
2.1
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
92
630
1.47
3.10
1.1
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
53
321
1.65
3.06
1.2
1.3
u/l
15.0
12.4
0.32
48
297
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
19
80
2.38
3.05
1.9
1.4
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
10
29
3.45
3.04
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
286
2331
1.24
2.98
1.6
1.7
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
5
5
10.00
2.97
1.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
5985
58581
1.10
2.97
22.1
13.8
%
39.7
40.1
2.40
4274
45201
(3047189) Immunofixation for 24 hour Urine
40
226
1.77
2.97
2.9
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
64
410
1.56
2.96
1.9
1.8
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
18
75
2.40
2.96
6.4
5.0
mg/l
27.6
20.5
1.78
18
70
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
81
547
1.49
2.95
1.1
1.3
titre
189.3
205.6
0.06
14
117
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
16
63
2.54
2.94
1.1
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
134
991
1.36
2.94
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
88
605
1.46
2.93
4.3
3.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
30
155
1.94
2.93
2.2
3.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
30
155
1.94
2.93
2.2
3.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
91
631
1.45
2.90
2.0
2.2
mg/l
27.0
22.4
0.24
17
170
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
34
184
1.85
2.90
2.3
2.6
umol/l
28.4
28.8
0.06
28
129
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
167
2158
0.77
2.89
1.4
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
42
243
1.73
2.88
4.4
4.5
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
112
809
1.39
2.85
1.7
1.8
titre
800.0
1277.8
—
5
37
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
22
103
2.14
2.79
3.2
2.1
mmol/l
7.4
7.5
0.05
12
57
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
28
513
0.54
2.72
1.4
1.5
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
7
14
5.00
2.72
3.6
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
49
301
1.63
2.72
3.0
4.4
mg/l
7.7
8.2
0.17
36
241
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
17
72
2.36
2.71
6.8
5.2
—
—
—
0
0
(4015189)
24
118
2.04
2.70
2.5
2.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
64
420
1.53
2.69
1.4
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
15
60
2.50
2.69
2.3
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
139
1050
1.33
2.69
2.8
3.6
u/ml
497.6
578.2
0.09
119
966
(3032868) Hemoglobin electrophoresis panel in Blood
17
73
2.33
2.64
1.6
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
284
2347
1.22
2.63
1.3
1.3
miu/ml
202.2
229.4
0.58
104
1113
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
264
2167
1.23
2.62
1.8
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
82
571
1.44
2.60
1.1
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
137
1039
1.32
2.59
2.5
2.7
umol/l
8.0
7.6
0.10
109
783
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1042
9498
1.11
2.57
2.2
2.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
51
322
1.59
2.55
1.0
1.0
ng/l
820.8
748.7
0.61
40
215
(4034850)
228
1848
1.24
2.55
11.4
8.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
51
323
1.58
2.53
1.0
1.0
ng/l
235.0
320.1
2.74
42
222
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
29
157
1.85
2.51
1.1
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
51
324
1.58
2.50
1.0
1.0
ng/l
33.4
44.5
1.59
41
217
(3036670) Protein [Mass/volume] in Synovial fluid
27
144
1.88
2.45
1.3
1.2
g/l
35.4
39.5
0.68
15
79
(3043238) Trisomy 21 risk [Likelihood] in Fetus
126
1648
0.76
2.44
1.5
1.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
10
34
2.94
2.40
4.0
4.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
16
70
2.29
2.40
1.0
1.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
18
83
2.17
2.40
1.2
1.2
u/ml
0.0
0.0
0.84
11
46
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
26
138
1.89
2.40
1.6
1.3
%
44.7
35.0
0.70
20
89
(3000492) Spirometry study
682
6093
1.13
2.39
1.5
1.4
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
30
167
1.80
2.39
4.1
2.0
mmol/l
0.8
1.6
1.76
18
128
(3000285) Sodium [Moles/volume] in Blood
15
64
2.34
2.38
1.7
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
98
717
1.37
2.37
1.2
1.1
%
98.1
95.6
0.42
90
674
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
359
3065
1.18
2.37
2.8
3.2
u/ml
108.3
49.6
0.31
342
2959
(3013166) Neutrophils/100 leukocytes in Synovial fluid
29
161
1.80
2.34
1.8
1.3
%
58.1
52.1
0.32
23
133
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
65
443
1.47
2.33
1.4
1.2
u/ml
25.4
43.8
—
8
37
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
15
65
2.31
2.30
1.4
1.6
%
9.4
7.2
—
8
35
(3013466) aPTT in Blood by Coagulation assay
10
35
2.86
2.30
1.1
1.1
s
32.3
36.9
—
10
30
(3050129) First trimester maternal screen panel - Serum or Plasma
207
2528
0.81
2.28
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
158
1987
0.79
2.27
1.4
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
8
203
0.39
2.27
1.8
3.0
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
6
13
4.62
2.27
1.2
1.1
nmol/24h
190.5
103.5
—
6
13
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
158
1985
0.79
2.26
1.4
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
20
99
2.02
2.25
1.1
1.1
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
7
18
3.89
2.25
1.0
1.2
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
7
18
3.89
2.25
1.4
1.1
mg/l
239.2
65.0
—
7
18
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
22
113
1.95
2.24
3.4
2.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
78
556
1.41
2.22
1.3
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
158
1981
0.79
2.22
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
442
3857
1.15
2.22
1.1
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
18
86
2.09
2.22
1.7
1.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
124
1600
0.77
2.21
1.4
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
20
100
2.00
2.19
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
23
121
1.90
2.19
2.3
2.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
10
36
2.78
2.19
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
460
4030
1.15
2.19
1.2
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
22
114
1.93
2.19
1.8
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
158
1977
0.79
2.19
1.4
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
70
492
1.43
2.17
1.7
1.4
e6/l
12169.2
74369.0
1.83
45
344
(3005033) Fetal Nuchal fold Thickness US
124
1594
0.77
2.15
1.4
1.4
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
20
101
1.98
2.14
2.1
3.8
%
4.0
3.7
—
10
37
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
9
30
3.00
2.14
1.1
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
131
1018
1.29
2.14
1.8
2.1
titre
1.2
2.4
—
5
25
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
13
55
2.36
2.11
1.2
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
69
487
1.42
2.10
1.4
1.5
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
10
37
2.70
2.10
1.2
1.3
—
—
—
0
0
(3025315) Body weight
12
49
2.45
2.10
4.9
3.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
74
529
1.40
2.09
9.4
5.8
%
11.5
11.4
0.11
74
529
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
20
102
1.96
2.09
1.1
1.3
mg/l
0.8
136.1
1.20
11
71
(3017315) Amylase [Enzymatic activity/volume] in Urine
46
300
1.54
2.07
1.9
1.3
u/l
204.1
361.1
1.63
41
275
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
7
20
3.50
2.05
1.1
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
20
3.50
2.05
1.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
219
1815
1.21
2.05
3.0
3.4
u/ml
132.6
3020.0
1.17
178
1548
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
53
358
1.48
2.03
1.6
1.4
u/ml
23.5
19.8
—
10
73
(3042010) Triglyceride [Moles/volume] in Pleural fluid
16
76
2.11
2.01
1.2
1.3
mmol/l
0.6
1.5
—
5
54
(3032641) Amino acids panel - Urine
8
26
3.08
2.01
1.4
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
9
32
2.81
1.99
1.4
1.3
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
18
91
1.98
1.94
1.2
1.3
ng/l
43.2
58.8
0.20
13
58
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
157
1265
1.25
1.94
1.6
1.7
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
22
120
1.83
1.91
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
33
203
1.63
1.91
2.2
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
66
472
1.40
1.89
1.2
1.2
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
18
92
1.96
1.89
1.1
1.2
mmol/l
1.3
1.7
—
8
61
(3040893) Potassium [Moles/volume] in Capillary blood
8
28
2.86
1.86
3.5
3.5
mmol/l
4.2
4.5
—
8
28
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
114
1448
0.78
1.85
1.3
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
62
442
1.41
1.82
2.1
2.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
130
1035
1.26
1.80
1.1
1.1
u/ml
4.0
3.9
0.03
52
488
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
7
23
3.04
1.79
5.6
5.4
umol/l
460.9
432.5
—
7
23
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
7
23
3.04
1.79
6.4
3.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
47
319
1.48
1.79
1.3
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
47
319
1.48
1.79
1.3
2.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
73
539
1.36
1.76
2.2
1.9
—
1.1
—
0
5
(3049233) Organic acids panel - Urine
10
41
2.44
1.75
1.0
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
18
3.33
1.74
1.3
1.2
%
1.7
2.6
—
6
18
(3004716) Salmonella sp identified in Stool by Organism specific culture
400
3535
1.14
1.74
1.4
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
26
155
1.68
1.71
1.2
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
30
186
1.61
1.71
1.8
1.5
ug/l
9.7
8.6
0.59
30
186
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
68
910
0.74
1.66
1.2
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
33
212
1.56
1.64
1.4
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
35
228
1.54
1.64
1.1
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
153
1847
0.82
1.60
1.4
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
28
174
1.61
1.60
1.8
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
17
91
1.87
1.60
1.2
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
8
32
2.50
1.59
1.3
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
16
84
1.91
1.59
2.9
2.8
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
46
321
1.43
1.56
1.1
1.2
u/ml
1.2
13.8
0.81
24
215
(3005082) Progesterone [Moles/volume] in Serum or Plasma
57
414
1.38
1.55
1.3
1.4
nmol/l
35.8
31.6
0.32
50
363
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
19
107
1.78
1.54
1.5
1.4
%
14.0
24.7
1.42
14
85
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
27
2.59
1.51
1.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
26
163
1.60
1.45
1.0
1.1
—
208.0
—
0
10
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
44
310
1.42
1.44
1.5
1.3
titre
60.0
483.5
—
6
23
(44813793)
68
515
1.32
1.44
1.1
1.1
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
5
16
3.12
1.43
1.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
16
3.12
1.43
1.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
12
59
2.03
1.43
1.2
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
22
133
1.65
1.41
2.9
3.6
u/l
45.7
98.3
0.73
11
41
(3015183) Erythrocyte sedimentation rate
49
354
1.39
1.40
1.2
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
69
527
1.31
1.39
1.5
1.4
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
11
53
2.08
1.38
1.0
1.2
mmol/l
4.0
5.8
—
5
30
(3028717) Thiamine [Mass/volume] in Blood
13
67
1.94
1.37
1.5
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
41
2.19
1.36
3.1
1.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
19
310
0.61
1.35
1.6
1.3
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
0
38
0.00
1.34
0.0
1.3
—
1.5
—
0
32
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
61
464
1.32
1.28
1.8
1.8
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
42
301
1.40
1.28
1.5
1.3
titre
66.0
68.5
—
5
26
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
10
48
2.08
1.27
1.1
1.1
u/l
9.3
15.2
—
10
48
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
95
767
1.24
1.26
1.1
1.3
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
8
36
2.22
1.24
1.0
2.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
32
220
1.46
1.22
2.8
2.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
8
37
2.16
1.21
1.8
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
414
3765
1.10
1.18
3.7
2.8
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
26
2.31
1.18
3.7
10.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
68
533
1.28
1.17
1.2
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
55
420
1.31
1.15
1.5
1.5
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
5
20
2.50
1.15
10.0
6.1
—
—
—
0
0
(4146454)
66
518
1.28
1.13
2.6
2.7
—
—
—
0
0
(4094501)
176
1523
1.16
1.13
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
596
5527
1.08
1.12
2.0
2.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
40
292
1.37
1.12
1.9
1.8
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
39
284
1.37
1.11
5.3
5.0
mg/l
68.7
68.1
0.02
31
219
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
752
7047
1.07
1.09
1.7
1.8
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
8
41
1.95
1.08
1.1
1.6
umol/24h
387.3
340.9
—
8
41
(3043410) Blood group antigens tested for on Red Blood Cells
24
160
1.50
1.08
1.9
1.6
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
12
66
1.82
1.08
1.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
21
136
1.54
1.08
1.4
2.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
68
541
1.26
1.06
1.3
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
70
559
1.25
1.06
1.5
1.5
e6/l
7460.7
2573.7
0.44
56
403
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
34
245
1.39
1.04
1.0
1.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
22
2.27
1.03
3.8
5.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
154
1331
1.16
1.03
2.1
2.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
34
2.06
1.02
1.0
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
9
47
1.91
1.02
1.1
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
10
53
1.89
1.01
1.1
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
72
582
1.24
1.00
1.1
1.2
u/ml
6.4
2.9
0.61
21
238
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
16
99
1.62
0.99
2.6
2.5
—
—
—
0
0
(44806071)
14
84
1.67
0.97
1.1
1.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
36
1.94
0.97
1.0
2.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
36
1.94
0.97
1.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
140
1211
1.16
0.95
1.1
1.1
au/ml
13.8
12.1
—
6
71
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
9
51
1.76
0.94
8.6
4.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
126
1082
1.17
0.94
1.3
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
37
1.89
0.94
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
813
7687
1.06
0.93
1.7
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
97
817
1.19
0.91
2.3
2.6
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
8
42
1.90
0.88
1.1
1.0
iu/ml
—
17.1
—
0
15
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
20
289
0.69
0.88
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
46
359
1.28
0.87
1.2
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
12
72
1.67
0.84
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
33
247
1.34
0.84
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
126
1094
1.15
0.84
1.6
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
59
478
1.24
0.84
1.5
1.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
36
274
1.31
0.83
1.3
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
8
140
0.57
0.82
1.4
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
473
4417
1.07
0.81
1.8
1.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
141
1239
1.14
0.80
4.2
3.4
mg/l
25.8
25.9
0.01
92
761
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
8
47
1.70
0.80
3.8
4.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1855
17988
1.04
0.79
1.5
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
10
58
1.72
0.79
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
348
3759
0.92
0.79
1.7
1.7
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
33
1.82
0.79
1.5
1.8
—
—
—
0
0
(3024471) HLA-A [Type]
33
251
1.32
0.77
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
148
1668
0.88
0.77
1.8
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
124
0.56
0.77
1.3
1.3
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
34
1.76
0.76
1.5
1.4
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
25
2.00
0.72
1.0
1.0
%
19.7
21.4
—
5
25
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
25
2.00
0.72
1.0
1.0
%
11.9
8.3
—
5
25
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
25
2.00
0.72
1.0
1.0
%
36.3
36.6
—
5
25
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
15
100
1.50
0.72
1.2
1.2
—
—
—
0
0
(3013762) Body weight Measured
5
26
1.92
0.70
1.0
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
41
1.71
0.69
4.3
2.9
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
115
1303
0.88
0.68
1.3
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
12
77
1.56
0.68
3.8
6.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1027
10666
0.96
0.68
1.5
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
16
110
1.45
0.68
1.3
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
49
595
0.82
0.67
1.3
1.6
mmol/l
7.8
7.6
0.28
28
365
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
17
119
1.43
0.66
1.2
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
23
303
0.76
0.63
3.9
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
59
497
1.19
0.62
3.3
3.0
mg/l
61.3
51.5
0.12
39
371
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
151
1364
1.11
0.60
1.3
1.2
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3035510) Gentamicin [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
4.2
—
1.0
—
0
12
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
19
139
1.37
0.60
1.3
1.2
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
35
282
1.24
0.57
2.2
2.0
ug/l
2.9
2.4
0.40
27
239
(3028308) Erythrocytes [#/volume] in Pleural fluid
59
502
1.18
0.57
1.5
1.4
e6/l
113344.4
65251.2
0.29
39
294
(3042951) Complement C1q Ab [Units/volume] in Serum
6
36
1.67
0.56
1.0
1.1
—
23.6
—
0
7
(3022670) pH of Venous cord blood
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
90
1.44
0.55
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
92
814
1.13
0.54
3.2
3.1
nmol/l
0.8
0.8
0.33
66
616
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
39
1.54
0.53
1.2
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
122
1100
1.11
0.52
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
30
242
1.24
0.50
1.3
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
99
1103
0.90
0.49
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
53
454
1.17
0.49
3.2
2.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
14
101
1.39
0.49
4.0
2.8
u/l
1168.8
1916.2
0.27
14
94
(3025130) Human papilloma virus identified in Specimen
80
902
0.89
0.49
1.7
1.8
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
7
45
1.55
0.48
1.1
1.1
—
4.3
—
0
6
(4281824)
49
572
0.86
0.48
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
113
1021
1.11
0.48
1.7
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
81
911
0.89
0.48
4.3
3.7
u/ml
73.5
31.7
0.55
81
881
(3022475) Manganese [Moles/volume] in Blood
7
46
1.52
0.48
1.1
1.3
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
35
290
1.21
0.47
1.1
1.1
u/ml
5.6
7.9
—
7
52
(3022689) Creatine [Moles/volume] in Urine
22
173
1.27
0.46
2.0
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
120
0.67
0.45
1.4
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
11
77
1.43
0.45
5.6
10.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
12
86
1.40
0.44
2.3
1.7
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
13
174
0.75
0.43
2.2
1.9
e6/l
6705.9
16104.4
—
8
94
(3041806) Other cells [#/volume] in Blood by Manual count
35
294
1.19
0.42
1.4
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
34
286
1.19
0.41
2.3
2.0
ug/l
4.4
3.0
0.44
27
257
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
8
59
1.36
0.41
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
52
454
1.15
0.40
1.5
1.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
11
79
1.39
0.40
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
784
8077
0.97
0.40
1.6
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
234
2204
1.06
0.40
1.4
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
18
141
1.28
0.40
1.3
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
18
141
1.28
0.40
1.3
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
18
141
1.28
0.40
1.3
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
12
160
0.75
0.39
2.2
2.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
190
1779
1.07
0.39
1.2
1.2
u/ml
2.6
1.9
0.21
72
838
(44806420)
16
124
1.29
0.38
2.3
2.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
9
67
1.34
0.38
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
36
419
0.86
0.37
1.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
116
0.69
0.36
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
173
1621
1.07
0.36
1.1
1.1
u/ml
3.8
6.1
1.35
81
946
(3009871) Measles virus Ab [Titer] in Serum
28
235
1.19
0.35
1.7
1.7
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
149
1390
1.07
0.35
1.4
1.5
pmol/l
88.7
144.5
1.69
144
1357
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
262
2489
1.05
0.35
1.8
1.7
mg/l
3.9
3.7
0.21
192
1741
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
122
0.74
0.35
1.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
43
1.39
0.35
1.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
22
265
0.83
0.34
2.2
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
78
856
0.91
0.34
1.1
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
6
45
1.33
0.33
1.0
1.1
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
6
46
1.30
0.33
12.5
9.7
e6/l
533.5
128.1
—
6
34
(3001729) Color of Synovial fluid
6
47
1.28
0.32
2.8
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
15
120
1.25
0.30
1.2
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
84
1.31
0.29
1.1
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
64
1.25
0.27
1.3
1.1
—
—
—
0
0
(4133840)
14
172
0.81
0.27
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
258
2475
1.04
0.26
1.8
1.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
216
2257
0.96
0.26
1.4
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
10
77
1.30
0.26
1.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
44
397
1.11
0.24
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
145
1524
0.95
0.23
1.1
1.1
u/ml
0.5
2.6
6.05
37
408
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
34
380
0.89
0.23
1.2
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
52
567
0.92
0.23
1.1
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
62
574
1.08
0.21
1.1
1.2
u/ml
2.0
8.6
1.06
16
208
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
12
0.00
0.21
0.0
1.5
—
2185.5
—
0
12
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
104
0.77
0.21
1.0
1.1
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
163
1564
1.04
0.19
1.1
1.1
u/ml
1.3
1.1
0.15
60
795
(3006598) pH of Arterial cord blood
10
122
0.82
0.19
1.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
117
1114
1.05
0.19
1.1
1.1
u/ml
4.5
5.3
0.21
46
491
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
27
241
1.12
0.19
2.5
2.4
mg/l
9.1
9.7
0.26
18
206
(3033799) Differential panel - Peritoneal fluid
14
164
0.85
0.18
1.9
2.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
50
463
1.08
0.18
1.5
1.8
mmol/l
7.0
6.4
0.82
32
335
(40761995) Spermatozoa Progressive [#/volume] in Semen
23
204
1.13
0.17
3.0
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
23
204
1.13
0.17
5.9
5.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
61
1.15
0.17
2.1
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
12
141
0.85
0.16
1.9
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
18
158
1.14
0.16
11.5
6.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
11
129
0.85
0.14
1.4
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
90
0.78
0.14
13.3
7.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
96
999
0.96
0.13
1.0
1.1
u/ml
0.1
0.4
2.24
19
279
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
114
1098
1.04
0.13
1.3
1.3
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
15
132
1.14
0.13
1.2
1.5
g/l
11.5
12.0
—
10
100
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
26
239
1.09
0.12
1.3
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
130
1259
1.03
0.12
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
15
168
0.89
0.11
1.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
95
1.16
0.11
1.5
4.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
130
1260
1.03
0.11
1.1
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
53
504
1.05
0.10
1.1
1.1
u/ml
0.4
1.5
—
9
95
(3037556) Urate [Mass/volume] in Serum or Plasma
13
146
0.89
0.10
1.6
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
144
1.11
0.10
10.6
6.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
32
300
1.07
0.09
6.4
6.4
u/ml
8243.1
9869.5
—
7
69
(4212803)
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
26
278
0.93
0.09
1.3
1.2
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
6
54
1.11
0.09
1.0
1.1
mg/l
11.4
9.8
—
6
48
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
56
537
1.04
0.08
1.1
1.1
iu/ml
6.3
8.9
0.67
15
130
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
58
1.03
0.08
2.0
2.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
68
1.03
0.07
1.6
2.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
6
71
0.84
0.07
1.2
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
30
285
1.05
0.06
4.0
3.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
49
507
0.97
0.06
1.2
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
27
284
0.95
0.06
2.0
2.0
ug/min
73.8
210.8
0.87
11
67
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
31
324
0.96
0.05
1.3
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
122
1201
1.02
0.04
1.1
1.1
u/ml
1.7
4.5
4.07
51
512
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
27
259
1.04
0.04
1.1
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
89
898
0.99
0.01
1.2
1.4
mmol/l
7.1
7.1
0.02
67
656
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
26
267
0.97
0.01
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
22
213
1.03
0.01
16.9
11.2
—
—
—
0
0
(4211845)
32
313
1.02
0.01
3.8
3.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
10
102
0.98
0.00
1.6
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
24
244
0.98
0.00
1.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
12
115
1.04
0.00
1.7
2.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
17
175
0.97
0.00
1.1
1.1
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
8
0.00
0.00
0.0
1.9
—
11.6
—
0
8
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
1294.3
—
0
7
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
84
0.95
0.00
19.4
9.2
—
—
—
0
0
(3020399) Glucose [Mass/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
69
1.01
0.00
1.9
1.9
—
—
—
0
0
(3017497) Pine Nut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3002853) Influenza virus B Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
18.8
—
0
5
(3040794) Aluminum [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: E4_PCOS_BROAD_EXCLUSIONS – Exclusions for E4_PCOS_BROAD

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).